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Phototransduction in vertebrate vision is mediated by visual pigments composed of 
opsin apoproteins covalently attached to a light-sensitive chromophore, 11-cis retinal. 
Absorption of light isomerizes 11-cis retinal to all-trans retinal, initiating a signal 
transduction cascade.  A complex set of enzyme reactions occurring in the retinal 
pigment epithelium and the retina is responsible for the synthesis and regeneration of the 
chromophore and is termed the visual cycle.  Several forms of inherited retinal 
degeneration and dysfunction manifest as a result of mutations in the genes associated 
with visual cycle function, such as RPE65 and RDH12. 
RPE65 is essential for the synthesis of 11-cis retinal and was recently confirmed to 
function as the visual cycle isomerase. Cone photoreceptors have been proposed to 
possess an exclusive chromophore regenerative pathway.  Using a monoclonal antibody 
approach, we have now mapped antigenic determinants of the protein surface, shown that 
RPE65 is not expressed in cone cells, and confirmed that RPE65 is associated with the 
visual cycle enzyme RDH5.   
Rdh12 has an in vitro activity and localization profile that made it an excellent 
candidate to serve as the all-trans retinal reductase of the visual cycle. Immunochemical 
analysis localized RDH12 protein to the photoreceptor inner segments and outer nuclear 
layer in both humans and mice, suggesting an equivalent physiological role for RDH12 in 
both species.  However, analysis of the phenotype of Rdh12-deficient mice revealed no 
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differences in histology, retinoid processing or electroretinogram response compared to 
wild-type. Rdh12-deficient mice did show a decreased ability to reduce all-trans retinal 
and 11-cis retinal as measured by in vitro activity assays of retinal homogenates. 
These findings suggest that RDH12 function in mice does not directly contribute to 
visual cycle function. Instead, a critical function of RDH12 is likely the reduction of 
retinaldehydes that exceed the reductive capacity of the photoreceptor outer segment and 
gain access to the inner segments in conditions of high illumination. The study of these 
genes is important not only to gain a better understanding of visual cycle mechanism, but 









The sage wisdom of one’s mother to ‘eat your carrots’ insomuch as to improve 
your vision is not entirely accurate. The consumption of foods high in beta carotene, the 
precursor of vitamin A, has not been shown to improve visual acuity.  However, it is true 
that vitamin A and its analogues are extremely important for the proper functioning of the 
eye.  The visual pigments of the eye, such as rhodopsin, are all bound to a chromophore 
that is required for sensing light and is derived metabolically from vitamin A.  The 
human eye contains some 105 million rods, each of those contains approximately 800 
stacked disc membranes, and each of these are studded with rhodopsin molecules at a 
density of approximately 25000 µm-2 (reviewed in [1]).  Each rhodopsin molecule is 
activated by a single photon of light and can react in as fast as 200 femtoseconds [2]. 
With billions of photons being present even in the dimmest environs, a constant supply of 
chromophore is critical for sustaining the visual response.  Fortunately, evolution has 
equipped vertebrate retinas with a metabolic pathway that serves to recycle the vitamin A 
necessary for chromophore production such that continuous dietary uptake is not required 
for sustained vision, and this pathway is termed the visual cycle. 
 Several forms of inherited retinal degeneration and dysfunction are caused by 
mutations in the genes encoding the enzymes and proteins necessary for visual cycle 
function. The study of these genes is important not only to gain a better understanding of 
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the visual cycle mechanism, but also to elucidate mechanisms of pathogenesis and to 
identify potential targets for rational therapies. 
Structure of the Retinal Pigment Epithelium and Neural Retina 
The retina is an extension of the central nervous system that detects, assimilates 
and transmits visual input to the brain.  In vertebrates, it has a highly organized structure 
composed of several distinct layers.  These layers are, from outside to inside: the retinal 
pigment epithelium (RPE); the photoreceptor outer segments (OS); the photoreceptor 
inner segments (IS); the external limiting membrane (EML); the photoreceptor outer 
nuclear layer (ONL); the outer plexiform layer (OPL), where photoreceptor cells synapse 
with interneurons; the inner nuclear layer (INL), containing the bipolar, amacrine and 
horizontal cells; the inner plexiform layer (IPL), where interneurons synapse with the 
ganglion cell layer; the nerve fiber layer (NFL); and the inner limiting membrane (ILM).  
Adjacent to the RPE lays the Bruch’s membrane, the choriocapillaris and the sclera.  The 
inner layers of the retina, from the OS to the ILM, are often referred to as the neural 
retina and consist of 6 main types of neurons in mammals - rod and cone photoreceptors, 
bipolar cells, horizontal cells, retinal ganglion cells and Müller cells (Figure 1-1). 
The RPE comprises a single layer of pigmented cells packed in a regular array 
with each cell having an approximately hexagonal shape.  The RPE represents a part of 
the blood-brain barrier, in this case referred to as the blood-retinal barrier.  The cells are 
sealed together by intracellular tight junctions resulting in this permeability barrier [3].  
These junctions also form a barrier between the apical and basolateral surfaces of the 
RPE cells [4].  The apical surface faces the retina and possesses microvilli that project 
into the interphotoreceptor matrix (IPM), surrounding the rod and cone photoreceptor 
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OS, while the basolateral surface faces Bruch’s membrane and contains smaller processes 
[5-7].  The RPE performs a number of specialized functions in the retina (reviewed in 
[8]).  In its role as the outer blood-retinal barrier, it is responsible for the active transport 
of essential metabolites, such as glucose and vitamin A, from the choroidal blood supply 
to the photoreceptors that lie too far from the retinal vasculature for passive diffusion [7].  
Differential expression of ion channels on the apical and basolateral membranes allow for 
the active transport of ions and water from the subretinal space, preventing retinal 
detachment [9]. Another critical function of the RPE is the phagocytosis, ingestion and 
breakdown of shed membranes from the photoreceptor OS.  The phototransductive 
elements of the photoreceptors are continuously renewed at the base of the OS, followed 
by shedding of the disc membranes from the tips. Lastly, the RPE serves a critical 
function in vitamin A metabolism, also referred to as retinoid processing, a point that will 
be covered extensively in the coming paragraphs. 
The photoreceptor cells are highly specialized neurons that transduce light stimuli 
into nerve signals, and have four distinct parts:  An outer segment that houses the bulk of 
the phototransductive machinery and is composed of stacks of bimembranous discs; an 
inner segment that contains the typical organelles necessary for cellular metabolism; a 
perikaryal zone that contains the cell nucleus and comprises the ONL; and a synaptic 
terminal that terminates at the OPL. Protein synthesis in photoreceptors takes place in the 
IS, and a slender connecting cilium joins the IS with the OS. All newly synthesized OS 
resident proteins must be transported within the IS and across the cilium to reach their 
destination. These phototransduction proteins are constantly turned over through 
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phagocytosis of the OS tips by RPE cells and the addition of the newly synthesized 
components at the base of the OS [10] (Figure 1-2).  
The two types of photoreceptor cells in the vertebrate retina are the rods and 
cones. Rods mediate vision in dim light and are more light-sensitive than cones, while 
cones are responsible for color and high acuity vision.  In most vertebrates, rods 
outnumber cones by as much as 20:1 and the retinas of these animals are dubbed ‘rod 
dominant’.  There are some exceptions to this, with species such as chickens and ground 
squirrels being ‘cone-dominant’. The rod and cone cells can be distinguished from one 
another by a number of morphological and biochemical characteristics.  Most notably in 
regards to ultrastructure, the OS of rods is cylindrical, while cone OS taper in width from 
the inner segment to the outer.  Additionally, the OS of both rods and cones contain 
stacks of membranous discs.  In rods, these discs become separated from the outer 
membrane, while in cones they maintain a connection to the surface membrane [11].  The 
photoreceptors can also be characterized by the expression of the visual pigments, with 
rhodopsin in rods and the cone opsins in cones.  Rhodopsin consists of an opsin 
apoprotein bound to a light sensitive chromophore, and has an absorption peak at ~498 
nm.  Trichromacy prevails in most primates (including humans) resulting in three cone 
subtypes, each expressing one of three forms of cone opsin:  short wavelength (blue) with 
an absorption peak ~420 nm (S-); medium wavelength (green) with an absorption peak 
~530 nm (M-); and long wavelength (red) with an absorption peak ~564 nm. Most other 
animals are dichromatic and thus have only two subtypes of cones, and in the mouse 
retina these are the S- and M- cones.  Rods are typically found throughout the retina, 
while cones are found at the highest density in the macula of primates, appearing as oval-
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shaped yellow spot near the center of the retina.  In mice, the cone photoreceptors are 
spatially distributed the dorsal to ventral direction. 
In the mouse, the different types of retinal neurons all develop from a pool of 
multipotent cells called retinal progenitor cells (RPCs). The retinal neurons are formed in 
a sequential order, albeit with significant overlap. The first cell types to arise are the 
retinal ganglion cells, the cones, the horizontal cells and the amacrine cells.  Rod cells are 
the next to begin developing in the late prenatal period, and continue to be formed into 
the postnatal period.  The Müller cells and bipolar cells begin to form in the early 
postnatal period.  By the end of the first postnatal week the retina has a clearly laminar 
structure, and connections between the various retinal neurons are formed during the 
second postnatal week [12]. The differentiation of RPCs into retinal neurons is influenced 
by a variety of external growth factors, and a number of transcription factors play 
important roles in determining the post-mitotic fate of the RPC.  One such transcription 
factor important to our studies was neural retina leucine zipper (NRL) protein.  A 
member of the musculoaponeurotic fibrosarcoma (Maf)-subfamily, NRL is expressed in 
the rod photoreceptors and regulates the expression of rhodopsin, rod phosphodiesterase 
(PDE6) and other rod-specific genes [13-16].  Targeted disruption of the Nrl gene in mice 
led to the hypothesis that Nrl plays a critical role in the differentiation of rod 
photoreceptors, as Nrl-knockout (Nrl–/–) mice possess a retina composed entirely of 
cones with S-cone-like characteristics [17].  This mouse model has been especially 




The Phototransduction Cascade 
The visual process in the retina begins when light is absorbed by visual pigments 
in the photoreceptor cells. These visual pigments, rhodopsin and cone opsins, are integral 
membrane proteins located in the discs of the OS of the rods and cones, respectively [18].  
The light-sensitive chromophore, 11-cis retinal, is covalently attached to the opsin 
proteins via a protonated Schiff base linkage to a specific lysine residue (K296 in human 
rhodopsin) located in one of seven transmembrane alpha helical segments [19]. Capture 
of a single photon results in the isomerization of 11-cis retinal to all-trans retinal. The 
markedly altered geometry of the retinal moves the Schiff base linkage approximately 5 
Å in relation to the ring portion of the chromophore [20]. Converting the photon into 
atomic motion, the conformational change results in the formation of the photoactive 
visual pigment (R*) that decays through a number of conformational intermediates [18]. 
One of these intermediates, meta II (MII), activates transducin, a heterotrimeric G-protein 
specific to photoreceptor cells.  Activation occurs by catalyzing guanosine diphosphate 
(GDP)–guanosine triphosphate (GTP) exchange on the α subunit of transducin (Tα), 
which is followed by dissociation of the active form of Tα from the Tβ and Tγ subunits. 
The Tα subunit in turn activates a photoreceptor-specific cyclic guanosine 
monophosphate (cGMP) phosphodiesterase (PDE), a multimeric enzyme of four subunits 
[21]. Upon activation, the two inhibitory γ subunits are released permitting the PDE α 
and β subunits to hydrolyze cGMP to 5’-GMP.   The resulting decrease in intracellular 
cGMP reduces the permeability of plasma membrane cGMP-gated cation channels, 
leading to hyperpolarization of the photoreceptor cell membrane and decreased 
neurotransmitter release at synapses with second-order retinal neurons [22, 23].  This 
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final step results in the propagation of the visual signal and the completion of the 
activation phase. 
Termination of the light response involves a number of steps which inactivate the 
transduction cascade and reset the sensitivity of the photoreceptor cells.  Recoverin, when 
bound to Ca2+, interacts with rhodopsin kinase and inhibits its ability to phosphorylate 
rhodopsin.   The decrease in intracellular Ca2+ that occurs during the photoresponse 
releases recoverin from rhodopsin kinase, which then phosphorylates R* at C-terminal 
serine and threonine residues [24, 25].  Arrestin binds to the phosphorylated opsins, 
preventing continued activation of transducin [26, 27]. Further decay of the active state 
results in hydrolysis of the Schiff base linkage and release of all-trans retinal from the 
opsin apoprotein. A GTPase activating protein (GAP) complex, composed of Regulator 
of G-protein signaling 9, G protein β subunit, and RGS9-1-Anchor Protein (RGS9-
1/Gβ5/R9AP), stimulates the intrinsic GTPase activity of transducin and allows the 
inactive complexes of both transducin and cGMP phosphodiesterase to reform [28]. 
Cytoplasmic levels of cGMP are restored by activation of photoreceptor-specific 
guanylate cyclases (GC1 and GC2) that are regulated by calcium-binding to guanylyl 
cyclase activating proteins [29-32].  (Figure 1-3) 
Light-Driven Translocation of Retinal Proteins 
An interesting phenomenon observed in the rod photoreceptors is the massive 
light-driven translocation of transducin, arrestin and recoverin between the major 
subcellular compartments of the photoreceptors. Most photoexcitation and recovery 
components, such as rhodopsin, PDE, the cGMP-gated channel, the RGS9-1/Gβ5/R9AP 
complex, and the retinal guanylyl cyclases are integral or peripheral membrane proteins 
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that reside in the OS regardless of illumination conditions. In contrast transducin, 
arrestin, and recoverin have been shown to undergo bidirectional translocations between 
the OS and IS in a light-dependent manner.  In dark-adapted photoreceptors, transducin 
and arrestin are concentrated in the OS and IS, respectively. Sufficiently bright light 
induces extensive and relatively rapid movement in rods, with transducin moving from 
the OS into the IS and the synaptic terminal, and arrestin moving from the IS into the OS. 
Recoverin translocates from the OS towards the synapse [33-39]. In cones, arrestin 
translocates to the OS in light, but only partial translocation of transducin is observed and 
this only under high intensity light [40-43]. Recoverin translocation has not yet been 
observed in cones. This light-dependent translocation of proteins may contribute to 
light/dark adaptation and could potentially protect the photoreceptor cell from light- and 
phototransduction-associated retinal degeneration [32, 36, 44]. (Figure 1-4) 
The Visual Cycle 
In order to sustain phototransduction, 11-cis retinal consumed as a result of the 
light activation of the visual pigments must be regenerated. The aggregate reactions 
responsible for this recycling are termed the visual cycle, and the conventional view is 
that vitamin A analogs cycle between the photoreceptor cells and the RPE, the major site 
of 11-cis retinal synthesis [45]. The chemical structures of the major vitamin A 
intermediates involved in RPE synthesis of 11-cis retinal and the cellular locations of the 
proteins and enzymes involved in this pathway are shown in (Figure 1-5). 
The visual cycle begins with the dissociation of all-trans retinal from the bleached 
visual pigments.  Some of the free all-trans retinal reacts with phosphatidylethanolamine 
(PE)  in disc membranes to form the Schiff base product N-retinylidene-
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phosphatidylethanolamine (NR-PE) until an equilibrium between the two forms is 
reached [46, 47].  The mechanism of all-trans retinal transport across the disc membrane 
to the photoreceptor cytoplasm and eventually the RPE has yet to be determined, but 
evidence points to a role for the retina-specific adenosine triphosphate (ATP)-binding 
cassette transporter (ABCR) [48-51].  Biochemical studies are consistent with an ATP-
switch model in which NR-PE binds to a high-affinity site on ABCR in the absence of 
ATP [52, 53]. This binding causes a conformational change that alters the affinity of the 
nucleotide binding domains (NBDs) for ATP [46, 48]. Binding of ATP to one or both 
NBDs causes dimerization of the NBDs and a conformational change in the protein. This 
converts the high-affinity NR-PE substrate binding site to a low-affinity site with access 
to the cytoplasmic side of the disc membrane, and is followed by dissociation of NR-PE 
from ABCR on the cytoplasmic side of the lipid bilayer [53].  
In the photoreceptor OS, free all-trans retinal is reduced to all-trans retinol, most 
likely by photoreceptor-specific retinol dehydrogenase (prRDH, or RDH8).  Retinol 
dehydrogenase/reductases, also referred to as RDHs, belong to the family of short chain 
acyl-CoA dehydrogenase/reductases (SDRs) [54-56].The resulting all-trans retinol is 
transported across the IPM to the RPE via a poorly defined process, potentially involving 
the interphotoreceptor/interstitial retinoid-binding protein (IRBP) present in the IPM, as 
well as passive diffusion [57]. All-trans retinol (vitamin A) is also supplied to the RPE 
from the blood supply via the choriocapillaris.  Uptake is a receptor-mediated process 
involving recognition of a serum retinol-binding protein/transthyretin (RBP/TTR) 
complex that is essential for sufficient uptake of retinol to support vision in the neonate 
[58-60]. Within the RPE, all-trans retinol is bound to cellular RBP (CRBP) [61]. 
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Three enzymes associated with the smooth endoplasmic reticulum of the RPE are 
required to convert vitamin A to 11-cis retinal.  The first enzyme, lecithin retinol 
acyltransferase (LRAT), esterifies all-trans retinol to phosphatidlycholine in the lipid 
bilayer to form all-trans retinyl esters [62-65]. These esters are then bound by the second 
enzyme, RPE-specific protein 65-kDa (RPE65), an abundant protein in the RPE that has 
a high affinity for all-trans retinyl esters [66].  In early studies, RPE65 was shown to be 
necessary for the isomerization reaction, but intrinsic isomerase activity was not detected 
[67].  However, recent studies have demonstrated that RPE65 is the retinoid 
isomerohydrolase of the visual cycle that converts all-trans retinyl esters to 11-cis retinol. 
[68, 69].  A third enzyme, 11-cis retinol dehydrogenase (11cisRDH), converts 11-cis 
retinol to the final aldehyde product in a reaction that is accelerated by the presence of 
cellular retinaldehyde-binding protein (CRALBP) [70-72]. Genetic studies have 
demonstrated that retinol dehydrogenase 5 (RDH5)- and retinol dehydrogenase 11 
(RDH11)-knockout mice have minor modifications in dark adaptation that are consistent 
with a role as the 11cisRDH in the visual cycle, and human mutations in RDH5 result in 
fundus albipunctatus [73-75]. Excess 11-cis retinol can also be esterified by LRAT and 
stored in the RPE as 11-cis retinyl esters when the cycle slows in the absence of light [76, 
77]. Finally, 11-cis retinal moves back to the rod photoreceptors, either in IRBP-
dependent or -independent fashion, where it joins with opsin to regenerate visual pigment 
[78-82]. 
Alternative mechanisms for the production of 11-cis retinal have been proposed. 
The RPE-retinal G-protein coupled receptor (RGR), expressed in the RPE and Müller 
cells, was initially proposed to function in a light-dependent pathway that regenerates 11-
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cis retinal [83-85]. The ligand for RGR is all-trans retinal, and was observed to isomerize 
to 11-cis retinal in response to illumination of the protein [86, 87]. RGR also associates 
with other visual cycle proteins, such as RDH5, and analysis of single RGR- and double 
RGR/RDH5-knockout mouse models suggest a nonessential role for RGR in the 
production of 11-cis retinal [88]. More recent studies have shown that RGR in fact 
modulates isomerohydrolase activity independent of light exposure, with the mode of this 
modulation still being researched [89-91]. 
Proposed Cone Visual Cycle 
While the rod photoreceptors have been shown to require the RPE to recycle 11-
cis retinal for rhodopsin regeneration, evidence has been presented that cones are distinct 
from rods in regard to retinoid processing [92, 93]. Cones have been suggested to have an 
alternative retinoid–metabolic pathway which functions independently of the RPE. 
RPE65 was proposed to directly participate in this cone visual cycle based on reported 
expression of RPE65 mRNA in salamander cones and protein expression in mammalian 
cones, but not in rod photoreceptors [94, 95]. This stood in conflict to data generated by 
our group, and will be further discussed in Chapter 2.  
Direct evidence of a light-driven cone cycle was obtained in the cone-rich chicken 
retina. Subsequent to dark adaptation, light exposure resulted in the accumulation of 11-
cis retinyl esters in the retina and all-trans retinyl esters in the RPE [96, 97]. The 
involvement of Müller cells in this pathway has been proposed, and a recent study has 
shown that cultured Müller cells from chickens can synthesize 11-cis retinyl esters from 
11-cis retinol, an activity enhanced by the presence of CRALBP [98, 99]. Other evidence 
came from the characterization of three novel enzyme activities in retina membrane 
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fractions from cone-dominated retinas (chicken and ground squirrel):  First, an 11-cis-
retinyl-ester synthase activity indicating that LRAT is not required for the synthesis of 
retinal esters in cones as it is in the RPE visual cycle;  second, an 11cisRDH activity in 
the retina that was found to prefer nicotinamide adenine dinucleotide phosphate 
(NADP+) as a cofactor rather than the NAD+ cofactor of the RPE visual cycle;  and 
third, an all-trans-retinol isomerase activity displaying the ability to convert all-trans 
retinol to 11-cis retinol without the synthesis of retinyl esters in the presence of CRBP 
[100, 101]. 
Inherited Forms of Retinal Degeneration 
 Various forms of inherited retinal dysfunction result from mutations in the genes 
necessary for visual cycle function and other aspects of retinoid processing, and exhibit a 
range of diverse phenotypes including retinitis pigmentosa, Stargardt disease and Leber 
congenital amaurosis (LCA).  The identification of these genes is an important aspect in 
furthering our understanding of the pathology of these diseases, as well as in designing 
effective therapies and treatments.     
LCA is the most early-onset and severe of all of the inherited retinal dystrophies.  
Accounting for approximately 5% of all retinal dystrophies, it is characterized by four 
clinical features: severe and early visual loss, sensory nystagmus (involuntary eye 
movement), amaurotic pupils (no light perception, but papillary contraction when 
opposite eye receives light stimuli), and absent electrical signals on an electroretinogram 
(ERG) [102].  Inheritance can be autosomal recessive or autosomal dominant, and is 
caused by defects in a number of genes.  To date, 14 genes have been found mutated in 
patients, estimated to account for 70% of all LCA cases. (reviewed in [103]).  While 
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these genes affect a number of aspects critical to the proper functioning of the retina, 
mutations were found in three genes encoding proteins associated with vitamin A 
metabolism:  LRAT, RPE65 and RDH12 [104-106].  The latter two have been the primary 
focus of my research endeavors, and will be further detailed in the following sections. 
Retinal Pigment Epithelium-specific Protein 65-kDa (RPE65) 
The RPE65 gene, located on chromosome 1p31 in humans and distal chromosome 
3 in mice, encodes a 533-amino acid protein that is evolutionarily conserved and is 
expressed in the RPE [107-109].  It is a marker gene for RPE differentiation, and its 
expression during development begins as the photoreceptors are formed in the retina 
[110, 111]. Mutations in RPE65 are associated with LCA, and targeted disruption of 
Rpe65 in mouse has shown that RPE65 is essential for synthesis of 11-cis retinal by the 
RPE [67, 104, 112, 113].  Additionally, the phenotype of the Rpe65-knockout (Rpe65–/–) 
mouse displays a mild disorganization of the rod photoreceptor OS, a lack of 11-cis 
retinoids and rhodopsin, and a lack of rod visual function as measured by ERG.  The 
Rpe65–/– mouse phenotype is similar to that present in Swedish briard dogs that 
experience progressive vision loss as a result of carrying a null functional allele of canine 
Rpe65 [114]. Rpe65-deficient mice are extremely insensitive to light, which protects 
them from light damage and establishes rhodopsin as the mediator of light-induced retinal 
damage [116, 117]. 
While RPE65 was found to be required for 11-cis retinal synthesis, no intrinsic 
isomerase activity was initially observed in assays of the recombinant protein.  However, 
addition of recombinant RPE65 to RPE microsomal membranes prepared from Rpe65–/–  
mice was found to restore retinoid isomerase activity [115].  It was proposed that, due to 
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its ability to bind to all-trans retinyl esters, RPE65 serves to present the ester substrate to 
the retinoid isomerase [118, 119].  Subsequently, during the time our work was ongoing, 
RPE65 was shown to possess isomerase activity in cell culture experiments in which 
LRAT was coexpressed [68, 69, 120].  Further studies showed that LRAT was not 
required for isomerization beyond the synthesis of the all-trans retinal ester substrate, and 
that RPE65 is an iron(II) dependent isomerohydrolase [121, 122].  In addition, RPE65 
missense variants present in individuals with LCA displayed loss-of-function when 
assayed for isomerase activity in vitro [120]. 
Formation of Dead-end Retinoid Products  
Excess retinaldehydes can form lipofuscin dead-end products that accumulate 
with aging.  Lipofuscin are fine, yellow-brown pigment granules that accumulate within 
the RPE as a result of aging [123]. The major fluorophore of lipofuscin has been 
identified as N-retinylidene-N-retinylethanolamine (A2E) and its isomers that form as a 
result of dephosphorylation of A2-PE [47].  A2-PE most likely forms infrequently during 
situations of increased intradiscal levels of all-trans retinal, which allow a second 
molecule of all-trans retinal to react with NRPE [124, 125]. These fluorophores then 
accumulate in the RPE when the shed OS are phagocytosed.  Stargardt’s disease is an 
early-onset form of macular dystrophy that is also characterized by increased levels of 
fluorescent lipofuscin deposits in the RPE, which are considered to result in atrophy of 
the RPE [126, 127].  Mutations in the ABCA4 gene encoding ABCR, whose proposed 
role was earlier described as trafficking NRPE to the cytoplasm of the rod 
photoreceptors, are a cause of autosomal recessive Stargardt disease. Areas of intense 
fundus autofluorescence in patients with age-related macular degeneration have been 
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shown to correspond to sites prone to atrophy, suggesting a link in the etiology of these 
diseases [128-130].   
Studies of susceptibility to light damage in various mouse strains identified a 
hypomorphic variant of mouse Rpe65.  These studies linked light-damage resistance in 
C57BL/6 albino mice with the chromosome 3 locus for Rpe65, identifying the Met450 
variant of Rpe65 in light-resistant mice and the Leu450 variant in light-sensitive mice of 
the albino BALB/c strain [131].  Resistance to light damage in C57BL/6 mice was 
directly associated with the Met450 variant, and correlated with lowered expression and 
lower overall activity of Rpe65 protein in all mice of the C57BL/6 strain [132, 133]. 
Additionally, mice possessing the Met450 variant displayed decreased levels of A2E and 
A2E isomers in retina and RPE compared to those with the Leu450 variant.  As RPE65 
has a rate-determining role in the visual cycle, reduced production of all-trans retinal that 
accompanies slowing of the regenerative pathway in the presence of the Met450 variant 
of RPE65 is likely responsible for the decreased formation of A2E [134]. 
Retinol Dehydrogenase 12 (RDH12) and Isoforms 
Retinoids comprise a family of isoprenoid lipids including vitamin A (all trans- 
retinol) and its natural and synthetic derivatives. Retinoids regulate a wide variety of 
essential biological processes, including development, cell growth arrest, differentiation 
and apoptosis, and homeostasis.  The oxidation and reduction of retinoids is critical to 
each of their explicit purposes, and this is particularly evident where the retinoids of the 




 RDH12 is a 316 amino acid, 35 kDa protein with transcript expression localized 
by in situ hybridization to the photoreceptor layer of the retina. In vitro analyses show it 
can metabolize both all-trans and 11-cis retinoids, and that it is an NADP(+)-dependent 
oxidoreductase capable of reducing retinal to retinol or oxidizing retinol to retinal, 
depending on substrate and cofactor availability [135, 136].  Mutations in RDH12 are 
linked to LCA, with most patient missense mutations causing profound loss of catalytic 
activity due to decreased protein stability [106, 137, 138]. In addition, RDH12 exhibits 
reductive capacity towards several other metabolic substrates in vitro, including C9 
aldehydes resulting from lipid photo-oxidation, as well as certain steroid substrates like 
dihydrotestosterone [136, 139, 140].   
Additional RDH isoforms that possess substrate specificity and activity 
comparable to RDH12 are also present in the retina and RPE. (Figure 1-6)  One of the 
earliest detected and most studied is RDH5, an 11-cis-retinol dehydrogenase expressed in 
the RPE [70, 71]. RDH5 has been shown to oxidize 11-cis retinol to 11-cis retinal in an 
NAD+ dependent manner, and has a very low activity toward all-trans retinol [141].  
Mutations in the human RDH5 gene were identified in individuals with delayed dark 
adaptation, and further analysis showed decreased activity of RDH5 mutant proteins to 
oxidize 11-cis-retinol [75]. Targeted disruption of Rdh5 in mice was shown to cause a 
large increase in the concentration of 11-cis retinol and 11-cis retinyl esters, but not to 
result in retinal degeneration nor affect normal dark adaptation [101, 142, 143].  These 
findings suggest that while RDH5 is a strong candidate for the 11-cis retinol 
dehydrogenase, other RDHs may participate in retinol oxidation in the RPE.   
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RDH8 (prRDH) is the only member of the RDH family so far found expressed in 
the rod photoreceptor OS. RDH8 utilizes NADPH as a cofactor to reduce both all-trans 
retinal and 11-cis retinal, although activity towards the latter is far lower [55].  While no 
mutations linked to human disease have been reported, an Rdh8-knockout (Rdh8–/–) 
mouse has been generated.  The Rdh8–/– mouse phenotype displayed no signs of 
degeneration or alteration in visual cycle throughput following brief light exposure.  
However, Rdh8-deficiency caused accumulation of all-trans retinal following exposure to 
bright light, delayed recovery of rod function as measured by ERG, and accumulation of 
A2E [56]. So while RDH8 can reduce all-trans retinal, it is not rate limiting for visual 
cycle function.  
RDH11 was first identified as an SDR expressed in pancreas, and expression was 
later found in the RPE and the photoreceptor IS [135, 144]. Human RDH11 has been 
purified and kinetically characterized in a manner similar to human RDH12, and has been 
found to act on all-trans and 11-cis retinoids in both an oxidative and reductive capacity, 
depending on the cofactor available (NADP+ or NADPH, respectively) [135, 145].  
However, with regards to the reduction of all-trans retinal, RDH12 has a greater Vmax 
value than RDH11 [136, 145].  Disruption of the Rdh11 gene in mice resulted in a 
phenotype with no obvious retinal defects, although a delay in dark adaptation was 
observed [73, 74].  RDH11 and RDH12 are highly related evolutionarily and are located 
in head-to-head orientation on the same chromosome in human and mouse [106, 146].  
Other RDHs expressed in the retina include DHRS3 (retSDR1), RDH10, RDH13 
and RDH14.  DHRS3 was reported to utilize NADPH as cofactor to catalyze the 
reduction of all-trans retinal to all-trans retinol [54]. No human DHRS3 mutations linked 
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to disease have been reported, nor has a knockout mouse been generated. RDH10 was 
found expressed in RPE and Müller cells, and was reported to utilize NADP+ as a 
cofactor to oxidize all-trans retinol in vitro [147, 148].  Mice deficient in Rdh10 
exhibited drastic limb, craniofacial, and organ defects.  This was found to be the result of 
abrogated Rdh10 oxidative activity needed to convert all-trans retinol to all-trans retinal, 
leading to insufficient retinoic acid signaling during embryogenesis [149]. RDH13 and 
RDH14 were initially identified based on sequence homology to RDH12 and RDH11.  
RDH13 is the mitochondrial form found expressed in the photoreceptor IS, and exhibited 
oxidoreductive activity towards retinoids, preferring NADPH as a cofactor, with a much 
greater catalytic efficiency as a reductase [135, 150].  RDH14 transcripts were localized 
to the photoreceptor IS. RDH14 activity was found to be similar to that of RDH11 and 
RDH12, acting in an oxidative and reductive capacity, depending on the cofactor 
available (NADP+ or NADPH, respectively) [135]. 
Synopsis of Dissertation 
RPE65 and RDH12 are disease genes associated with severe forms of retinal 
dystrophy. RPE65 has been shown to be critical for visual cycle function, and better 
understanding of its structure and function will be critical to the improvement of current 
therapeutic measures. The severity of the phenotype caused by RDH12 mutations is 
consistent with a nonredundant role in photoreceptor physiology.  When in vitro activity 
toward retinoids is considered, RDH12 has the potential to play a unique role in the 
visual cycle mechanism as an all-trans retinol dehydrogenase.  The role of RDH12 in 
retinoid processing in the retina and disease pathogenesis is a major focus of our research 
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endeavors as outlined in this dissertation. I have evaluated these issues and documented 
my findings in the following chapters: 
1. To further define the role of RPE65 in the visual cycle through the characterization of 
RPE65 expression, surface epitopes and protein-protein interactions, I employed a 
monoclonal antibody approach. Immunohistochemical analysis showed that RPE65 is not 
expressed in cone cells, thus excluding a proposed direct role of RPE65 in a cone 
regenerative pathway of 11-cis retinal synthesis. Immunoaffinity studies mapped 
antigenic determinants of the protein surface and found that RPE65 is associated with the 
visual cycle enzyme RDH5.  (Chapter 2) 
2. To evaluate RDH12 protein expression and determine whether subcellular localization 
supports its proposed role as a visual cycle retinoid reductase, I generated an anti-RDH12 
antibody. When used for western and immunohistochemical analysis, this antibody 
showed that RDH12 expression is confined to the photoreceptor IS in both human and 
mouse.  This suggests an equivalent physiological role for RDH12 in both species, but at 
the same time places it away from the phototransduction reactions occurring in the OS. 
Additionally, functional characterization of a RDH12 knockout mouse revealed no 
differences in histology, retinoid processing or ERG response compared to wild-type, 
suggesting that Rdh12 function in mice does not directly contribute to visual cycle 
function. (Chapter 3) 
3. To determine the effects of Rdh12 deficiency on the retinoid reductase activity of the 
retina as well as retinoid processing, I performed in vitro reductase assays of Rdh12-
knockout and wild-type mouse retinal homogenates towards retinaldehydes substrates.  
This showed that the reductive capacity of the Rdh12-deficient mouse is greatly 
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decreased compared to the wild-type.  In addition, transcript levels of Rdh12 correlated 
with visual cycle activity as determined by the genetic background of the mouse.  These 
findings suggest that one role of RDH12 is likely the reduction of retinaldehydes that 






Figure 1-1. Structure of the human eye and the layers of the retina. This illustration 
points out the major anatomical features of the human eye. Light enters the eye through 
the cornea, passing through the lens and the anterior chamber (delineated by the red 
vertical dashed line) which is composed mostly of the vitreous humor before striking the 
retina.  The blown-up section of the eye shows the layers of the retina, with the major cell 
types of the retina labeled. The layers of the retina, from outside to inside (and viewed 
here top to bottom) they are: retinal pigment epithelium (RPE), outer segments (OS), 
inner segments (IS), external limiting membrane (ELM), outer nuclear layer (ONL), outer 
plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL), ganglion 
cell layer (GCL), inner limiting membrane (ILM) and nerve fiber layer (NFL). This 







Figure 1-2. Structure of the rod and cone photoreceptors.  This schematic depicts the 
major divisions of the photoreceptors, which are:  the outer segment composed of stacks 
of bimembranous discs which contain the phototransductive machinery, the inner 
segment that contains the mitochondria and other cellular metabolism organelles; the 
outer nuclear layer which contains the cell nucleus; and the synaptic terminal where 









Figure 1-3. Phototransduction cascade activation and inactivation. This illustration 
depicts three rod discs, and to the right a representation of the plasma membrane. The top 
disc illustrates inactive rhodopsin (R), transducin (Gα, Gβ, and Gγ subunits), and PDE (α, 
β, and γ subunits) in the dark. Adjacent to the right, calcium and sodium channels in the 
plasma membrane as open in response to guanylate cyclase (GC), shown converting GTP 
to cGMP. The middle disc shows the activation of transducin and PDE in response to 
light stimuli, while the adjacent plasma membrane shows the ion channels as having shut 
due to decreased cellular levels of cGMP- a result of PDE activation.  The reactions in 
the bottom disc represent inactivation of active rhodopsin via phosphorylation by 
rhodopsin kinase (RK) followed by arrestin (Arr) binding and transducin/PDE 
inactivation by the RGS9-1/Gβ5/R9AP complex. Cytoplasmic levels of cGMP are 







Figure 1-4. Translocating proteins in visual signal transduction. Schematic 
illustration of transducin, arrestin and recoverin distribution in dark-adapted and light-
adapted rods. In rods, transducin moves out of the outer segment and accumulates 
primarily in a region known as the inner segment, arrestin moves in the opposite 
direction, and recoverin shifts from the outer segment towards the synapse. In cones, 
arrestin but not transducin moves in light; recoverin translocation has not yet been 
analyzed in cones The subcellular rod compartments are abbreviated on the right: OS, 
outer segment; IS, inner segment; N, nucleus; ST, synaptic terminal. This figure is 






Figure 1-5. The visual cycle. Schematic of the visual cycle mechanism showing the 
interconversion of vitamin A analogs and necessary enzyme activities. RPE, retinal 






Figure 1-6. RDH Isoforms in the retina.  This schematic shows the localization of the 
major RDH isoforms present in the retina, as based on the current data.  RPE, Retinal 
pigment epithelium; ROS/COS, rod or cone outer segment; RIS/CIS, rod or cone inner 
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CHAPTER 2  
 
RPE65 SURFACE EPITOPES, PROTEIN INTERACTIONS, AND EXPRESSION 




RPE65 is an abundant protein expressed in the RPE where its function in the 
visual cycle is necessary for the synthesis of 11-cis retinal, the chromophore of the visual 
pigments [67, 109]. Developmentally, RPE65 is an important marker for the 
differentiated phenotype of the RPE [111]. Mutations in the gene encoding RPE65 are 
associated with early-onset forms of autosomal recessive severe retinal dystrophy, 
including Leber congenital amaurosis in an estimated 5% of cases. [103, 104, 112, 113, 
154]. A number of research groups over the years have been involved in efforts to 
develop therapeutic methods specific for RPE65 loss-of-function [155-158].  These 
efforts have culminated in recent clinical trials of gene replacement therapy, in which 
patients suffering from advanced stages of LCA displayed improvement in visual 
function [159-162]. 
Studies have shown that RPE65 functions as the retinoid isomerohydrolase in the 
RPE that converts all-trans retinyl esters to 11-cis retinol by coupling the free energy of 
ester hydrolysis to the trans to cis isomerization reaction [68, 69, 120, 163]. This role is 
in agreement with earlier studies, the results of which show that RPE65 is a retinoid-
                                                 
* Portions of this chapter were published in:   
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binding protein [66, 118, 164].  A molecular switch mechanism whereby RPE65 binds 
all-trans retinyl esters when palmitoylated on Cys231, Cys329, and Cys330 by LRAT, 
but binds all-trans retinol when depalmitoylated, was proposed [165]. However, further 
studies showed that LRAT activity was not required beyond the synthesis of the all-trans 
retinyl ester substrate [122]. Pathogenesis associated with RPE65 loss-of-function has 
been proposed to result from constitutive opsin activity due to loss of chromophore [117, 
166, 167], although alternative interpretations have also been put forward [168].  
The relatively high incidence of RPE65 mutations in patients with early-onset 
retinal dystrophy, as well as its central role in current therapeutic efforts, created a strong 
incentive to garner a mechanistic understanding of RPE65 in the context of visual cycle 
function. Among the many critical issues to resolve include elucidating the mechanism 
by which missense mutations disrupt RPE65 function, and establishing the role of RPE65 
in rod- and cone-associated visual cycles. Cones have been proposed to have a private 
pathway of visual pigment regeneration that may involve their ability to oxidize 11-cis 
retinol to 11-cis retinal [96-98, 100]. RPE65 has been proposed to directly participate in 
the cone visual cycle based on its reported expression in cones [94, 95]. 
For studies of RPE65 expression, function, and structure, our lab developed 
monoclonal antibodies specific for RPE65. One of these, mAb 8B11, elicited using RPE 
membranes as immunogen, has been widely distributed and used in various applications 
[107, 169-172].  A second antibody, mAb 1F9, was elicited using an RPE65 synthetic 
peptide.  Studies outlined in this chapter report on the generation and utility of this 
second antibody to corroborate standing evidence regarding aspects of RPE65 structure, 
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interactions with other proteins of the visual cycle, and pattern of immunoreactivity in 
eyes from rod- and cone-dominated species. 
 
Materials and Methods 
Synthesis of RPE65 synthetic peptides 
The antigenic index for RPE65 was calculated using the Jameson-Wolf prediction 
of the Protean module in Lasergene suite of software (DNA STAR, Inc., Madison, WI). 
Peptides of interest were synthesized by the University of Michigan Protein Facility. For 
use as immunogen, peptide 1 (50-FHHINTYEDNGFLIV-64), peptide 2 (312-
FHHINTYEDNGFLIV-326) and peptide 3 (444-PDRLCKLNVKTETWV-459) 
corresponding to the human RPE65 protein were synthesized with an added carboxy-
terminal cysteine residue and conjugated to keyhole limpet cyanin (KLH) using Imject 
Maleimide Activated Immunogen Conjugation Kit (Pierce Chemical Co., Rockford, IL) 
according to manufacturer's instructions. Peptides were similarly conjugated to 
ovalbumin for use as substrates in enzyme-linked immunosorbent assays (ELISAs). A 
peptide of the 8B11 epitope (154- KVNPETLETI-163) was generated for use in 
immunoaffinity assays, as was RPE65 peptide 93-MTEKRIVITE-102 (peptide 18), for 
the assessment of nonspecific effects. 
mAb production and screening 
The protocol used for mAb production adhered to the Association for Research in 
Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and 
Vision Research and was performed by the University of Michigan Diabetes Research 
and Training Center hybridoma facility. Six-week-old BALB/c female mice were 
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immunized by intraperitoneal injection with 40 μg of KLH-conjugated peptide 
FHHINTYEDNGFLIV. mAb 8B11 was previously generated by immunization bovine 
RPE microsomal membranes and the corresponding antigenic determinant was mapped to 
the sequence 154- KVNPETLETI-163 by ELISA) [107, 173-175]. A minimum of three 
immunizations in adjuvant were given at three week intervals, and fusions were 
performed using standard procedures [176, 177] and the AGA-X63.653 cell line [178]. 
Hybridoma supernates were screened by ELISA using bovine RPE membranes or peptide 
FHHINTYEDNGFLIV conjugated to ovalbumin as substrates, and subsequently 
screened by western and immunohistochemical analysis, as described below. For western 
analysis, bovine RPE and mouse RPE/choroid membrane proteins were separated by 
sodium dodecyl sulfate-polycrylamide gel electrophoresis (SDS-PAGE), transferred to 
nitrocellulose, and incubated with primary and secondary antibody (alkaline phosphatase-
conjugated) using standard methods [179]. Typing of antibody class and subclass was 
performed using ImmunoPure Monoclonal Antibody Isotyping Kit (Pierce Chemical Co.) 
according to manufacturer's instructions. Hybridomas producing RPE65 antibodies were 
expanded and grown in culture for six weeks prior to harvest. Immunoglobulin G (IgG) 
was isolated from ascites fluid obtained from in vivo hybridoma cultures using 
chromatography on diethylaminoethyl-Sepharose in high salt [180] or protein-A 
Sepharose (Prosep A kit, Millipore Corp., Billerica, MA). 
Immunohistochemical analysis 
For cryosections, eyes were fixed in cold 4% paraformaldehyde (mice and rats 
were first perfused with PBS, then 4% paraformaldehyde), washed in PBS, transitioned 
to sucrose/Optimal Cutting Temperature compound (OCT), frozen in dry-ice cooled 
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hexanes, and 10 μm sections cut through the retina/choroid/RPE (for large eyes) or whole 
globes (for small eyes). For mAb 8B11, sections (except mouse) were blocked with 20% 
sheep serum and 0.2% Triton X-100 (Sigma-Aldrich, St. Louis, MO) in PBS, incubated 
with mAb 8B11 (2 μg/ml) for 2 h, then with Alexa Fluor 555-conjugated anti-mouse IgG 
(1:500; Molecular Probes, Inc., Eugene, OR) for 1 h. For mouse sections with mAb 
8B11, and all sections with mAb 1F9 (30 μg/ml), the Mouse on Mouse (M.O.M.) 
Peroxidase kit (Vector Laboratories, Burlington, CA) was used for blocking and antibody 
incubation (1 h at RT), and the tyramide signal amplification (TSA)-Alexa Fluor 568 kit 
(Molecular Probes, Inc.) was used for visualization. 
For retina flatmounts, mouse eyes were enucleated and the retinas dissected and 
fixed in cold 4% paraformaldehyde for 1 h. Immunohistochemistry and lectin labeling 
was performed essentially as in [94]. In brief, retinas were washed in PBS, blocked with 
20% sheep serum and 0.2% Triton X-100 in PBS, incubated with mAb 8B11 or mAb 1F9 
and fluorescein isothiocyanate (FITC)-conjugated peanut agglutinin (PNA)-lectin (0.05 
mg/ml; Molecular Probes, Inc.) in 2% sheep serum and 0.2% Triton X-100 in PBS for 12 
h, washed and incubated in the same buffer with Alexa Fluor 555-conjugated anti-mouse 
IgG (1:500) for 12 h. Alternatively, retinas were incubated with mAb 8B11 (2 μg/ml) and 
rabbit anti-S-opsin (1:500) or anti-M/L-opsin (1:500, Chemicon International, Inc., 
Temecula, CA) for 12 h, then with Alexa Fluor 555-conjugated anti-mouse IgG (1:500) 
and Alexa Fluor 488-conjugated anti-rabbit IgG (1:400) for 12 h. 
Specimens were viewed and photographed on a Nikon Eclipse E800 microscope 
with a Nikon DMX1200 digital camera using the manufacturer's data acquisition 
software. Phase contrast and fluorescence images were obtained (FITC-PNA lectin, 488 
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nm; Alexa Fluor, 555 and 568 nm). The approximate ages of the eyes used for 
immunohistochemical analysis were: human, 49 years; bovine, 4 months; wild-type 
(B6/129) mouse, 40 days; Rpe65-knockout (Rpe65–/–)  mouse, 50 days; Nrl-knockout 
(Nrl–/–) mouse, 42 days; rat, 6 months; Xenopus laevis, 4 week; and chicken, 4 months. 
Immunoadsorption and peptide elution 
Affinity matrices were generated by crosslinking mAb 8B11 or mAb 1F9 to 
cyanogen bromide-activated Sepharose 4B (Amersham Biosciences, Piscataway, NJ) 
according to manufacturer's instructions. Bovine RPE membranes (200 μg) were 
solubilized in 10 mM sodium phosphate, 150 mM NaCl, pH 7.0, and Complete protease 
inhibitors (Roche Diagnostics Corp., Indianapolis, IN) containing either 0.8% CHAPS, 
0.8% octylglucoside, 0.5% laurylmaltoside, or 0.5% Genapol. The solubilized 
membranes were incubated with affinity matrix (50 μl) overnight at 4 °C, then washed 
and eluted by incubation with 500 μM peptide (100 μl) for 1 h at RT in the same 
detergent solution used for solubilization, but at lower concentrations (0.7% CHAPS, 
0.7% octylglucoside, 0.2% laurylmaltoside, or 0.2% Genapol). The eluted proteins were 
analyzed by SDS-PAGE, coomassie blue staining, and western analysis using mAb 8B11 
or mAb 1F9, and antibodies against 11-cis retinal dehydrogenase (RDH5) [135], the 
retinal G protein-coupled receptor (RGR) [85], and lecithin retinol acyl transferase 
(LRAT) [181]. 
Generation of predicted RPE65 tertiary structures 
A low-resolution model of the tertiary structure of the RPE65 protein was 
derived, ab initio, by submitting the human RPE65 amino acid sequence (GenBank 
AAA99012) to the automated I-sites/HMMSTR/Rosetta server [182]. The server 
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automates a process of modeling tertiary structure from amino acid sequence using 
HMMSTR, a hidden Markov model based on protein structures in the invariant or 
initiation folding sites (I-sites) library of nonredundant short sequence motifs 
(supersecondary structures) that correlate with local structures [183], coupled with the 
Rosetta program to build structures from protein fragments [184]. The resulting tertiary 
structure with predicted coordinates was visualized and displayed with Discover Studio 
ViewerPro 5.0 (Accelrys, San Diego, CA). 
A second model of RPE65 tertiary structure was generated using the recently 
solved structure of the apocarotenoid-cleaving oxygenase from Synechocystis sp. PCC 
6803 (PDB 2biw:a) as a template; a member of the retinal-forming carotenoid 
oxygenases protein family of which RPE65 and β-carotene-15, 15'-oxygenase are 
members [185]. Using the functions for matching and aligning available in Swiss-
PDBViewer/DeepView (version 3.71b1), the human RPE65 amino acid sequence was 
placed into the structure of PDB 2biw and the resulting file was submitted to the SWISS-
MODEL server [186]. The resulting tertiary structure with coordinates was displayed and 




In screens of hybridomas generated from mice immunized with bovine RPE 
membranes, clone 8B11 (IgG1 kappa) was found to produce a high-affinity monoclonal 
antibody specific for RPE65 in western analysis of bovine RPE membranes (Figure 2-2). 
Specificity for RPE65 was further demonstrated by comparison of immunoreactivity in 
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mouse eye sections from wild-type and Rpe65–/– mice that showed reactivity only in the 
RPE of the wild-type animals (Figure 2-3). 
 The production of the novel anti-RPE65 antibody began with the creation of 
three synthetic peptides selected based upon the antigenic profile of human RPE65 
(Figure 2-1).  Mice were immunized with one of these peptides, with the most robust 
anti-sera derived from the mouse treated with peptide 2 (312-FHHINTYEDNGFLIV-
326).  This resulted in the identification of a hybridoma producing a monoclonal 
antibody, 1F9 (IgG1 kappa), specific for RPE65 in westerns of bovine RPE membranes 
(Figure 2-2) and in immunohistochemical analysis of wild-type and Rpe65–/– mice 
(Figure 2-3). However, the working concentrations of mAb 1F9 needed were at least 10 
fold greater than those for mAb 8B11 (Figure 2-2). This is indicative of the relatively 
lower affinity of mAb 1F9 for the bovine and mouse proteins compared to mAb 8B11. 
RPE65 immunoaffinity purification 
To determine whether the epitopes recognized by mAb 8B11 and mAb 1F9 are 
accessible on the surface of RPE65, and to establish a mechanism for purifying the native 
protein, bovine RPE membranes solubilized in non-ionic detergents were incubated with 
immunoaffinity matrices, followed by elution with various RPE65 peptides. 
When RPE membrane proteins were incubated with a mAb 8B11 affinity matrix, RPE65 
could be bound and specifically eluted by incubation with peptides containing the 
KVNPETLETI sequence, appearing as a 61 kDa band on coomassie blue stained gels. 
Results obtained using CHAPS and elution with the KVNPETLETI peptide 
corresponding to the 8B11 epitope are shown in Figure 2-4. Peptide 18, another peptide 
from RPE65, was used a control for nonspecific elution. Comparable results were 
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obtained using laurylmaltoside, octylglucoside, or Genapol, with the identity of RPE65 
confirmed by western analysis ( Figure 2-4). The amount of RPE65 recovered by peptide 
elution was somewhat less than when the affinity matrix was eluted by stripping with 
SDS sample buffer. However, elution with SDS sample buffer also resulted in the release 
of small amounts of IgG light chain (MW about 25 kDa) from the matrix (presumably 
due to reduction of intramolecular disulfide linkages), as well as trace amounts of 
nonspecifically bound protein. Residual RPE65 remaining on the matrix following 
elution with KVNPETLETI-containing peptides was also released by SDS stripping, 
suggesting that RPE65 undergoes significant hydrophobic interaction with the solid 
support, a situation also observed using a non-immune mouse IgG affinity matrix.  
Similar results were obtained for purification of RPE65 from bovine RPE 
membranes using the mAb 1F9 affinity matrix eluted with the FHHINTYEDNGFLIV 
peptide, with some differences (Figure 2-4). The mAb 1F9 matrix was effective at 
binding RPE65, however incubation with nonspecific peptides resulted in leaching of 
RPE65 from the matrix, and total yields of purified protein were significantly less than 
obtained with mAb 8B11; both effects are presumably due to the lower apparent affinity 
of mAb 1F9 for bovine RPE65. In addition, purification trials using the non-ionic 
detergent Genapol were not successful. 
The finding that affinity matrices made using either mAb 8B11 or mAb 1F9 are 
effective for immunoadsorption of RPE65 solubilized in non-ionic detergent is consistent 
with the interpretation that the corresponding antigenic amino acid sequences are located 




Visual cycle protein co-purifies with RPE65 
Although RPE65 preparations obtained by affinity purification appeared to be 
relatively pure on coomassie blue-stained gels, western analysis was used to assess 
whether visual cycle proteins that potentially associate with RPE65 in vivo were co-
eluted in our protocols. Immunoblots of the proteins eluted from the mAb 8B11 matrix 
with KVNPETLETI and probed with an antibody against the 11-cis retinol 
dehydrogenase RDH5 (approximately 35 kDa) showed that small amounts of RDH5 co-
eluted with RPE65 in all four detergents tested (Figure 2-4) [135]. Trace amounts of 
RDH5 were also seen on blots of the proteins eluted from the mAb 1F9 matrix using 
FHHINTYEDNGFLIV in laurylmaltoside (Figure 2-4). For both mAb 8B11 and mAb 
1F9 matrices, as well as non-immune IgG matrix, RDH5 in significant amounts was seen 
in SDS-sample buffer eluates, consistent with nonspecific interactions of RDH5 with the 
solid support. In contrast, western analysis using antibodies against RGR and LRAT did 
not detect these RPE proteins in peptide eluates of either mAb 8B11 or mAb 1F9 
matrices (data not shown) [85, 181]. 
Predicted tertiary structure and epitope placement 
Two approaches were used to generate structural models of RPE65 useful for 
experimental interpretation and design. First, a low-resolution tertiary structure for 
RPE65 was predicted from the primary sequence using the I-sites/HMMSTR/Rosetta 
server that automates the use of protein folding rules to predict local, secondary, and 
supersecondary structures using a Markov state to represent a position in an I-site motif, 
coupled with the Rosetta program to build structures from protein fragments using a 
Monte Carlo simulated annealing algorithm [182-184] (Figure 2-5). A second model was 
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generated based on the recently solved structure of the apocarotenoid-cleaving oxygenase 
from Synechocystis sp. PCC 6803 [PDB 2biw:a], a member of the retinal-forming 
carotenoid oxygenase family that contains RPE65 and β-carotene-15, 15'-oxygenase 
[185]. In DeepView, the RPE65 sequence was aligned and fit to the PDB 2biw sequence, 
the resulting structure was further modeled by the SWISS-MODEL server, and the 
coordinates annotated in DS ViewerPro [186] (Figure 2-5). The resulting RPE65 
structures with predicted coordinates were displayed and annotated to highlight the 
epitope recognized by mAb 8B11 and mAb 1F9, and the locations of the amino acid 
substitutions resulting from patient missense mutations. The KVNPETLETI sequence 
recognized by mAb 8B11 and the FHHINTYEDNGFLIV sequence used to elicit mAb 
1F9 both localize to surface exposed loops that are relatively unstructured. No predicted 
sites of posttranslational modifications or patient mutations are present within the mAb 
8B11 antigenic determinant. However, the mAb 1F9 peptide contains both sites of patient 
mutations (N321K, 962-963 ins A) and potential interaction with metal ions (His313). 
Immunohistochemical analysis of species and tissue specificity 
To establish the specificity of RPE65 expression in eyes with rod- and cone-
dominant retinas, mAb 8B11 and mAb 1F9 reactivity was assessed using 
immunohistochemical analysis of retina/RPE/choroid or whole globe cryosections from 
various species. With mAb 8B11, intense reactivity restricted to the RPE layer was seen 
in human, bovine, and rat; all species having rod dominant retinas (Figure 2-6). mAb 
8B11 reactivity was also seen only in the RPE in chicken and Xenopus laevis whose 
retinas contain a high ratio of cone to rod cells, as well as in Nrl–/– mice whose retinas 
contain exclusively cone-like photoreceptor cells [17, 187-189]. With mAb 1F9, 
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immunoreactivity confined to the RPE layer was seen in human, bovine, and the Nrl–/– 
mouse (Figure 2-7). However, mAb 1F9 reactivity was completely absent in chicken and 
Xenopus, apparently due to lack of crossreactivity with RPE65 protein from these species 
as a result of sequence differences. 
The reactivity of mAb 8B11 and mAb 1F9 was also evaluated in retina flatmounts 
and compared to the pattern of cone labeling using PNA-lectin, as well as to the reactivity 
of antibodies against S-opsin and M/L-opsin present in the cone photoreceptor outer 
segments (OS) (Figure 2-8). Retinas were from wild-type mice (C57BL/6/Sv129), 
Rpe65–/– mice in which no protein is detected, and Nrl–/– mice [67]. In all three mouse 
genotypes, no RPE65 immunoreactivity could be seen in cones or any other cells of the 
retina using either antibody, establishing that the absence of signal in retina/RPE/choroid 
sections was not due to masking by the intense signal from the RPE. 
 
Discussion 
A new monoclonal antibody against RPE65 has been developed and reactivity 
compared to that of the well studied anti-RPE65 antibody mAb 8B11. We have shown 
that a second human RPE65 sequence, FHHINTYEDNGFLIV, is also antigenic. The 
corresponding mAb 1F9 exhibits specificity similar to mAb 8B11 that is specific for 
KVNPETLETI, but has a lower affinity and a lower degree of reactivity across species, 
most likely due to differences in amino acid sequence between species.  The 
KVNPETLETI sequence is conserved among bovine, newt, and frog RPE65 orthologs, 
and differs only at the second position (Ile vs. Val) in human, monkey, rat, mouse, dog, 
chicken, and salamander. It is interesting to note that, in studies by others in which 
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RPE65 antibodies were developed by immunization with synthetic peptides, the most 
effective antibodies obtained were elicited by 150-NFITKVNPETLETIK-164 containing 
the epitope recognized by mAb 8B11 [190]. The convergence of these two different 
approaches to RPE65 antibody production on the same amino acid sequence suggests that 
this region possesses high antigenicity. 
The antigenic determinants recognized by mAb 8B11 and mAb 1F9 are amino 
acid sequences likely to be present on the RPE65 protein surface. The ability of each 
antibody to recognize native RPE65 solubilized in non-ionic detergents made it possible 
to develop immunoaffinity purification protocols effective in purifying RPE65 from 
bovine RPE membranes, and from transfected COS-7 cells expressing the recombinant 
protein (data not shown).  Establishing the surface accessibility of the KVNPETLETI and 
FHHINTYEDNGFLIV epitopes represented a first step toward validating predicted 
models of RPE65 tertiary structure derived using ab initio and comparative methods, 
confirming the potential utility of such models in future experimental design. 
Preparations of RPE65 purified from bovine RPE membranes using mAb 1F9 or 
mAb 8B11 immunoaffinity chromatography were found to contain co-eluted RDH5 that 
was observable by western analysis. Only small amounts of RDH5 were detected, even 
when washes were performed in the cold using minimum times and volumes, and various 
detergents. RDH5 is an abundant protein in the RPE that appears to undergo significant 
nonspecific interaction with the affinity matrix solid support. However, two other visual 
processing proteins, RGR and LRAT, that are relatively abundant in the RPE and likely 
to interact with RPE65, were not detected in immunoaffinity purified material. It is 
therefore likely that the co-purification of RDH5 with RPE65 reflects a high affinity 
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association of these proteins in vivo, rather than a nonspecific effect. This is in agreement 
with previous studies reporting that RDH5 co-purifies with RPE65 when nonspecific 
methods of elution (e.g. high pH) are used [70]. Studies to determine whether RPE65 and 
RDH5 exist in a stable retinoid processing complex in vivo have to date been 
inconclusive. 
Analysis of immunoreactivity in eye cross-sections and retina flatmounts using 
mAb 8B11 detected RPE65 expression only in the RPE in a number of species that have 
rod- or cone-dominant retinas, including Xenopus laevis (~40% cones), chicken (~ 60% 
cones), and the Nrl–/– mouse in which the cone-like phenotype of the photoreceptor cells 
has been established on the basis of a number of morphological, molecular, and 
electrophysiological criteria that distinguish the photoreceptors from rods [17, 187-189, 
191, 192]. Corroborating data were obtained using mAb 1F9 to assess immunoreactivity 
in mouse, human, and Nrl–/– mouse. Our finding of RPE65 expression only in the RPE 
and not in retina is in agreement with an earlier study where this issue was addressed in 
the mouse [193]. In contrast, studies by Ma and coworkers reported RPE65 expression in 
cones, first detecting RPE65 mRNA in salamander cones using reverse transcriptase-
coupled polymerase chain reaction and then finding RPE65 immunoreactivity in mouse, 
bovine, rabbit, and Xenopus laevis retina flatmounts using a polyclonal antibody elicited 
against 150-NFITKVNPETLETIK-164 [94, 95]. Curiously, in the second study a higher 
density of labeled cells was seen in rod-dominant mouse, bovine, and rabbit retinas than 
in Xenopus laevis retinas comprised of 30% cones, an incongruity not discussed by the 
authors. Also of note, the reactivity of preimmune serum on the retina flatmounts was not 
shown. Our studies do not exclude the possibility that extremely low level expression of 
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RPE65 exists outside the RPE. In fact, in a recent study, low level RPE65 expression in 
the ciliary body was detected using RT-PCR and western analysis, but not by 
immunohistochemistry [194].  It remains to be seen whether reported cone expression is 
genuine or a result of contamination of retina preparations with small amounts of RPE, a 
valid concern considering the close physical association between the two tissues. 
We conclude that the primary site of RPE65 function is in the RPE-based visual 
cycle, as we find no physical evidence to suggest a direct role of RPE65 in an alternate 
visual cycle involving cone cells. The identification of two distinct RPE65 surface 
epitopes represented a first step toward developing a structural understanding of this 
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Figure 2-1. Schematic of RPE65 amino acid sequence. RPE65 antigenic index 
calculated using the Jameson-Wolf prediction in the DNASTAR program Protean. 
Positions of synthetic peptides 1-3 corresponding to the 3 sequences of highest predicted 
antigenicity (excluding the 8B11 epitope) are shown underlined in the enlarged section.  
Amino acid sequences of the 8B11 epitope and the non-specific synthetic peptide used in 







Figure 2-2. Immunoreactivity of mAb 8B11 and mAb 1F9 with bovine RPE 
membranes. A: Coomassie blue staining of proteins separated by SDS-PAGE (20 μg 
protein). B: Western analysis (1 μg protein) of proteins separated by SDS-PAGE, 
transferred to nitrocellulose, incubated with mAb 811 (0.2 μg/ml), or mAb 1F9 (3 μg/ml), 
and immunoreactivity visualized using alkaline phosphatase coupled anti-mouse IgG. 










Figure 2-3. Immunohistochemical analysis of mAb 8B11 and mAb 1F9 reactivity in 
wild-type and Rpe65–/– mice. Cryosections were incubated with mAb 8B11 (2 μg/ml) 
or mAb 1F9 (30 μg/ml) using M.O.M. Peroxidase reagents, with visualization using 
TSA-Alexa Fluor 568 reagents and using fluorescence imaging (1/30 s). Phase contrast 






Figure 2-4. RPE65 immunoadsorption and peptide elution. A, C: Bovine RPE 
membranes in CHAPS (A) or bovine RPE membranes in laurylmaltoside (B) were 
incubated with mAb 8B11-Sepharose (A) or with mAb 1F9-Sepharose (B). Coomassie 
blue stained gels of proteins eluted with the KVNPETLETI peptide corresponding to the 
mAb 8B11 epitope (A), with the FHHINTYEDNGFLIV peptide used to generate mAb 
1F9 (B), with peptide 18 corresponding to an RPE65 sequence that did not compete in 
ELISA's, or with SDS-sample buffer. C, D: Western analysis of bovine RPE membranes 
in various detergents immunoabsorbed on mAb 8B11-Sepharose (C), or on mAb 1F9-
Sepharose (D), and eluted with peptides or SDS-sample buffer, as shown. Proteins were 
transferred to nitrocellulose and probed with mAb 8B11 (C), mAb 1F9 (E), or an 
antibody against RDH5 (C, D), and reactivity visualized using alkaline phosphatase 
coupled anti-mouse IgG. Arrows indicate the positions of RPE65 and RDH5. CH 
represents CHAPS; OC represents octylglucoside; GP represents Genapol; LM represents 
laurylmaltoside; mIgG represents nonspecific mIgG-Sepharose matrix; 8B11 represents 
KVNPETLETI; 1F9 represents FHHINTYEDNGFLIV; 8B11, SDS represents peptide 
KVNPETLETI eluted matrix subsequently eluted by SDS; 1F9, SDS represents peptide 







Figure 2-5. Models of RPE65 tertiary structure. A: An ab initio model of the three-
dimensional structure for the RPE65 protein was predicted using the method of Bystroff 
and Shao [182]. B: A correlative model of the three-dimensional structure for the RPE65 
protein was predicted by comparison to the apocarotenoid-cleaving oxygenase from 
Synechocystis and modeled by the SWISS-MODEL server [186]. The ribbon 
representing the peptide backbone is color coded according to structural components: α-
helices are green; β-pleated sheets are blue; and random coil is gray. The linear sequence 
corresponding to the epitope recognized by mAb 8B11 is shown in purple and for mAb 
1F9 is shown in pink. Sites of amino acid substitutions resulting from patient missense 








Figure 2-6. Immunohistochemical analysis of mAb 8B11 reactivity in rod- and cone-
dominant retinas. Retina/choroid/RPE cryosections of paraformaldehyde-fixed eyes 
from bovine, human, rat (rod-dominant), and from Xenopus laevis, chicken, Nrl–/– 
mouse (cone-dominant) were incubated with mAb 8B11 or mouse non-immune IgG, and 
immunoreactivity was visualized with Alexa Fluor 555-conjugated anti-mouse IgG using 
fluorescence imaging. Retina/choroid/RPE cryosections from paraformaldehyde eyes 
were incubated with mAb 8B11 or mouse non-immune IgG, and reactivity was visualized 
with Alexa Fluor 555-conjugated anti-mouse IgG using fluorescence imaging. Phase 
contrast (A,D,G,J,M,P), mAb 8B11 reactivity (B,E,H,K,N,Q), non-immune mouse IgG 
reactivity (C,F,I,L,O,R). Bovine sections are from an amelanotic region of the RPE. The 






Figure 2-7. Immunohistochemical analysis of mAb 1F9 reactivity in rod- and cone-
dominant retinas. Retina/choroid/RPE cryosections of paraformaldehyde-fixed eyes 
from bovine, human (rod-dominant), and from Xenopus laevis, chicken, Nrl–/– mouse 
(cone-dominant) were incubated with mAb 1F9 or mouse non-immune IgG using 
M.O.M. Peroxidase reagents, and visualized using TSA-Alexa Fluor 568 reagents using 
fluorescence imaging (1/50 s human, all others 1/30 s). Phase contrast (A,D,G,J,M), mAb 
1F9 reactivity (B,E,H,K,N), non-immune mouse IgG reactivity (C,F,I,L,O). Bovine 






Figure 2-8. Immunohistochemical analysis of retina flatmounts.  Retinas from wild-
type (A,B,G,H), Rpe65–/– (C,D,I,J), and Nrl–/– mouse (E,F,K-N) were fixed on 
coverslips and incubated with PNA-lectin (FITC-conjugated), mAb 8B11, mAb 1F9, or 
antibodies against S-opsin and M/L-opsin. Alexa Fluor 555-conjugated anti-mouse IgG 
was used as secondary antibody. PNA labeling (A,C,E,G,I,K), mAb 8B11 labeling 
(B,D,F), mAb 1F9 labeling (H,J,L), S-opsin labeling (M), M/L-opsin labeling, (N). 
Fluorescence imaging: PNA-lectin, opsin antibodies 1/60 s; mAb 8B11 1/12 s; mAb 1F9, 
1/20 s. The scale bars represent 50 μm. 
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CHAPTER 3  
 





Retinoid dehydrogenases/reductases (RDHs) perform critical oxidation-reduction 
reactions in the visual cycle mechanism that converts vitamin A (all-trans retinol) to 11-
cis retinal, the light-absorbing chromophore of the visual pigments in photoreceptor cells 
[195]. One of these reactions involves the oxidation of 11-cis retinol produced by retinoid 
isomerohydrolase activity in the retinal pigment epithelium (RPE), resulting in formation 
of 11-cis retinal that is delivered to the photoreceptor cell outer segments (OS). The 
second reaction involves reduction of all-trans retinal released from rhodopsin and cone 
opsins upon bleaching, resulting in formation of all-trans retinol that is returned to the 
RPE for trans-to-cis isomerization. A number of RDH isoforms are expressed in the RPE 
and/or the neural retina that differ in terms of substrate specificity and sites of expression. 
Within the RPE, RDH5 is thought to be the key enzyme involved in converting 
11-cis retinol to 11-cis retinal [70]. Mutations in RDH5 in humans result in fundus 
                                                 
† Portions of this chapter were published in:   
Kurth I, Thompson DA, Rüther K, Feathers KL, Chrispell JD, Schroth J, McHenry CL, Schweizer M, 
Skosyrski S, Gal A, Hübner CA. Targeted disruption of the murine retinal dehydrogenase gene Rdh12 does 
not limit visual cycle function.  Mol Cell Biol. 2007 Feb;27(4):1370-9.; Copyright © American Society for 
Microbiology; 
And 
Chrispell JD, Feathers KL, Kane MA, Kim CY, Brooks M, Khanna R, Kurth I, Hübner CA, Gal A, Mears 
AJ, Swaroop A, Napoli JL, Sparrow JR, Thompson DA. Rdh12 activity and effects on retinoid processing 
in the murine retina. J Biol Chem. 2009 Aug 7;284(32):21468-77. 
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albipunctatus, a form of congenital stationary night blindness [75]. Since Rdh5-knockout 
mice exhibit very mild visual disturbances, it has been suggested that RDH5 activity may 
be redundant with that of other isoforms [142]. Consistent with this notion, mice deficient 
for Rdh11 and for Rdh8, two isoforms expressed in the photoreceptors, exhibit a mild 
phenotype without signs of retinal degeneration [73, 74]. Functional interaction of RDH5 
with RDH11 has been proposed, but studies showing that RDH11 is expressed in the 
photoreceptor cell inner segment (IS) complicate this interpretation [73, 74]. RDH10 is 
expressed in both the RPE and Müller cells and is specific for the oxidation of all-trans 
retinol [147]. At least five RDH isoforms, including RDH8, RDH11, RDH12, RDH14, 
and DHRS3, have been reported to be expressed in the photoreceptor cells [55, 135, 196]. 
In vitro, each exhibits substrate specificity compatible with a role in converting all-trans 
retinal to all-trans retinol in the recovery phase of the visual cycle. 
Mutations in RDH12 cause a severe form of autosomal-recessive retinal 
dystrophy (arRD) with childhood onset that is often diagnosed as Leber congenital 
amaurosis [106, 137, 138]. The severe phenotype associated with RDH12 mutations is 
consistent with a nonredundant role of RDH12 in photoreceptor physiology, leading to 
the notion that it may play a unique role in the visual cycle mechanism. RDH12 has also 
been proposed to detoxify medium-chain aldehydes potentially present in the 
photoreceptors as a result of lipid peroxidation [136]. 
In order to better understand the potential role of RDH isoforms in the visual 
cycle and other critical functions of the photoreceptors, we have characterized the spatio-
temporal expression of members of this family within the retina.  In addition, a 
collaboration was established with Ingo Kurth and Christian Hübner of the Institut für 
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Humangenetik (Hamburg, Germany) in which these researchers generated an Rdh12-
knockout (Rdh12–/–) mouse. The gene targeting strategy used resulted in deletion of 
Rdh12 exons 1 to 3, encoding the N-terminal one-third of the protein (Figure 3-1). To 
exclude side effects from the neomycin selection cassette, the neo gene was removed 
from the targeted allele by Cre-mediated excision in the embryonic stem cells used to 
generate the engineered mice.  We characterized the retinal phenotype of this Rdh12–/– 
mouse using functional assays.  Our findings suggest that the phenotype associated with 
RDH12 deficiency does not result from disruption of visual cycle function, and leave 
open the possibility that multiple RDH isoforms may contribute to the regulation of the 
oxidation state of retinoids in the outer retina. 
 
Materials and Methods 
All experimental procedures complied with the regulations of the University of 
Michigan Committee on Use and Care of Animals and the ARVO Statement for the Use 
of Animals in Ophthalmic and Vision Research.  Rdh12–/– mice were obtained from 
Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, 
Germany, reared in a 12h-12h light-dark cycle (~800-lux room light, as indicated below) 
and euthanized by CO2 inhalation. 
Analysis of Rpe65 genotypes 
Mice were genotyped for an Rpe65 polymorphism, p.Leu450Met, which affects 
the efficiency of 11-cis retinal synthesis [126]. PCR products (~300 bp) were obtained 
(sense primer, 5'-GCATACGGACTTGGGTTGAATCAC-3'; antisense primer, 5'-
GGTTGAGAAACAAAGATGGGTTCAG-3') and digested with the restriction enzyme 
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MwoI, which recognizes the Leu450 allele, and the pattern of cutting was evaluated on 
agarose gels. Studies were performed in a mixed 129Sv;C57BL/6 background, using the 
F3 and F4 generations. Littermates matched for Rpe65 genotype, as indicated, served as 
controls. 
Antibody development 
Antibodies specific for human or mouse RDH12 were raised against synthetic 
peptide sequences chosen on the basis of predicted antigenicity and uniqueness within the 
family of RDH proteins. Peptides were coupled via an N-terminal cysteine to the keyhole 
limpet hemocyanin carrier protein. For the generation of an antibody against human 
RDH12, mice were immunized with one of three peptides:  peptide 1, C-
PSIRKFFAGGVCRTNVQ (amino acids 20 to 36, with an additional N-terminal 
cysteine); peptide 2, C-SAASEIRVDTKNSQ (amino acids 78 to 91, with an additional 
N-terminal cysteine); and peptide 3, C-DCKRTWVSPRARNNKT (amino acids 284 to 
299, with an additional N-terminal cysteine; Protein Data Bank accession number 
gi:19343614).  Sera from the mouse immunized with peptide 3 gave the most robust and 
specific response, and a hybridoma cell line secreting monoclonal antibody (mAb) 2C9 
was generated and used to elicit ascites fluid in mice.  IgG was purified from ascites on 
protein A-Sepharose by using standard protocols [180]. For mouse Rdh12, rabbits were 
immunized against the peptide CKRMWVSSRARNKKT (amino acids 285 to 299; 
Protein Data Bank accession number gi:58037513) or C-SPFFKSTSQGAQ (amino acids 
252 to 263, with an additional N-terminal cysteine), and each resulting antiserum (termed 
rAb CKR or rAb CSP, respectively) was purified on an affinity matrix made by 





Mouse eyes were enucleated and homogenized in sodium dodecyl sulfate sample 
buffer, insoluble material was removed by low-speed centrifugation, and proteins were 
separated by polyacrylamide gel electrophoresis and blotted onto membranes by using 
standard protocols. Blots were probed by incubation with the affinity-purified rAb CSP 
rabbit antiserum diluted 1:500, and reactivity was detected using an alkaline phosphatase-
coupled secondary antibody (1:4,000; GE Healthcare). Human retinas were dissected 
from postmortem donor eyes (Midwest Eye Bank and Transplantation Center), 
homogenized in sodium dodecyl sulfate sample buffer, electrophoresed, and blotted as 
described for mouse eyes. Blots were probed by incubation with mAb 2C9 IgG (~0.5 
µg/ml), and reactivity was detected using an alkaline phosphatase-conjugated secondary 
antibody (1:500; Molecular Probes). Western analysis of COS-7 cells transfected with 
cDNA constructs encoding either mouse or human RDH12 with an amino-terminal His 
tag (pcDNA3.1/HIS) and probed with anti-Xpress antibody served as a positive control. 
Immunohistochemistry 
Mouse eyes were enucleated, and corneas were removed. The eye cups were fixed 
in 4% paraformaldehyde in PBS for 30 min at 4°C, washed three times for 5 min each 
with PBS, placed in 20% sucrose in PBS at 4°C overnight, and then flash frozen in 
Tissue-Tek O.C.T. Sections (8 µm) were blocked with 3% normal goat serum and 0.3% 
Triton X-100 in PBS for 30 min, incubated with primary antibody (rAb CSP [1:500] or 
anti-rhodopsin) or fluorescein isothiocyanate-conjugated peanut agglutinin (PNA)-lectin 
(0.05 mg/ml; Molecular Probes) in blocking solution overnight, washed three times for 5 
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min each with PBS, incubated with Alexa Fluor 488- or 555-conjugated secondary 
antibody (1:3,000; Molecular Probes) and Toto-3 for counterstaining of nuclei (1:10,000; 
Molecular Probes) in blocking solution for 2 h, washed, and covered with coverslips.  
For images of protein translocation, anesthetized mice (∼3 months old) were 
perfused with 4% paraformaldehyde in 0.1 M sodium phosphate, pH 7.4, the eyes were 
enucleated and post-fixed (total fixation time ≤ 15 min) and rinsed in phosphate buffer, 
and the anterior segments and lenses were removed. The posterior eyecups were 
transitioned through a sucrose series and flash-frozen in sucrose-OCT. Cryosections (18 
μm) were permeabilized with 0.125% Triton X-100 in PBS, treated with biotin blocking 
reagents (Invitrogen), blocked with 1% bovine serum albumin, 10% normal goat serum, 
and 0.125% Triton X-100 in PBS for 1 h, and then incubated overnight at 4 °C with 
primary antibody in 1% bovine serum albumin, 1% normal goat serum, and 0.125% 
Triton X-100 in PBS and washed. Sections were incubated with biotinylated anti-rabbit 
secondary antibody (1:400; Molecular Probes) for 3 h, washed, and incubated with 
streptavidin-Alexa Fluor-488 or -555 (Molecular Probes, 1:500). Sections were washed, 
mounted in ProLong Gold containing 4′, 6-diamidino-2-phenylindole (DAPI) (Molecular 
Probes) to stain nuclei, and imaged using an Olympus FV500 confocal microscope with 
FluoView FV500 data acquisition software. 
Human eyes were dissected to obtain pieces of retina/RPE/choroid/sclera that 
were fixed in 4% paraformaldehyde for 15 min, placed in 20% sucrose for 5 min, and 
then flash frozen in Tissue-Tek O.C.T. Sections (10 µm) were blocked with 20% sheep 
serum and 0.2% Triton X-100 in PBS, incubated with primary antibody (mAb 2C9, ~1 
µg/ml; anti-rhodopsin, 1:1,000; or anti-prRDH, 1:25) or FITC-conjugated PNA-lectin 
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(0.05 mg/ml; Molecular Probes) in 2% sheep serum and 0.2% Triton X-100 in PBS, 
washed, and incubated in the same buffer with Alexa Fluor 488- or 555-conjugated 
secondary antibody. Specimens were viewed and photographed either with a confocal 
microscope (Leica TCS) or on a Nikon Eclipse E800 microscope with a Nikon 
DMX1200 digital camera, using the manufacturer's data acquisition software. 
Morphological analysis 
For high-power micrographs and electron microscopy, mice were perfused with 
4% paraformaldehyde and 1% glutaraldehyde in phosphate-buffered saline (PBS). 
Tissues were postfixed in 1% OsO4, dehydrated, and embedded in Epon. Sections (0.5 
µm) were stained with methylene blue. Ultrathin sections (60 nm) were stained with 
uranyl acetate and lead citrate and viewed and photographed using a Zeiss EM 902 
microscope. 
Assays of oxidative stress indicators 
Mice were subjected to bleaching light (5,000 lux for 30 min) before being 
sacrificed. Lipid peroxidation products potentially resulting from photooxidation were 
assayed as thiobarbituric reactive substances (TBARs) in retinal homogenates in RIPA 
buffer [136, 197]. The transcript abundance of heme oxygenase 1 (HO-1), a marker for 
oxidative stress, was assayed in retinal total RNA by using quantitative PCR (sense 
primer, 5'-GCATGCCCCAGGATTTGTC-3'; antisense primer, 5'-
CTGGCCCTTCTGAAAGTTCCTCATG-3') and was normalized with respect to Hprt 





Analysis of retinoid content 
Mice were allowed to dark adapt or were exposed to various light regimens and 
then were euthanized.  Eyes were then enucleated and frozen in liquid N2 in the dark. 
Retinoids were extracted using a modification of a previously described method [198]. 
Briefly, under dim red light and on ice, two eyes were homogenized in 1 ml 
chloroform:methanol:hydroxylamine (2 M) (3:6:1) and incubated at room temperature for 
2 min. Next, 200 µl chloroform and 240 µl water were added, and each sample was 
vortexed and centrifuged at 14,000 rpm for 5 min. The lower phase was collected, the 
solvent was evaporated under N2, and the sample was dissolved in hexane. Retinoids in 
the extracts were identified and quantified by high-performance liquid chromatography 
(HPLC) analysis, using a Waters Alliance separation module and photodiode array 
detector with a Supelcosil LC-31 column (25 cm by 4.6 mm by 3 µm) developed with 5% 
1,4-dioxane in hexane. For quantification of retinyl esters, the column effluent at 3 to 6 
min was collected and saponified by incubation in ethanolic KOH (40 mM) at 55°C for 
30 min, and the products were then extracted into hexane and subjected to HPLC analysis 
as described above. Peak identification was done by comparison to retention times of 
standard compounds and evaluation of wavelength maxima. Quantitative analysis was 
done by comparison of peak areas and published extinction coefficients: at 325 nm for 
all-trans retinol (εM = 51800 M cm-1); 318 nm for 11-cis retinol (εM = 34320 M cm-1); 
357 nm for syn-all-trans retinal oxime (εM = 55500 M cm-1); 361 nm for anti-all-trans 
retinal oxime (εM = 51700 M cm-1); 347 nm for syn-11-cis retinal oxime (εM = 35900 M 
cm-1); 351 nm for anti-11-cis retinal oxime (εM = 30000 M cm-1); and 325 nm for all-
trans retinal esters (εM = 49256 M cm-1) [199]. Data were analyzed using analysis of 
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variance (α= 0.05) (Excel software), and statistical differences were designated for P 
values of <0.05. 
 
Results 
RDH12 antibody development and immunoreactivity 
 Three synthetic peptides were used to illicit anti-RDH12 antibodies in mice, 
selected based upon the antigenic profile of human RDH12 (Figure 3-2A). The most 
robust serum was derived from the mouse treated with peptide 3 (284-
DCKRTWVSPRARNNKT-299).  This resulted in the identification of a hybridoma 
producing a monoclonal antibody, mAb 2C9.  Specificity was established by Western 
analysis of COS-7 cells transfected with a cDNA encoding Xpress-tagged human 
RDH12, in which mAb 2C9 was shown to recognize the same bands as those recognized 
by anti-Xpress antibody that correspond to glycosylated and unglycosylated forms of 
RDH12 [106]. These immunoreactive bands were not seen in western blots of 
untransfected cells or COS-7 cells transfected with RDH11- or DHRS3-encoding cDNAs 
(Figure 3-3B), nor in COS-7 cells transfected with RDH5-encoding cDNA (data not 
shown). The three bands recognized by mAb 2C9 in cells expressing RDH12 are, from 
lowest to highest molecular weight:  untagged RDH12 at ~33 kDa, a result of translation 
from the native start (ATG) codon; a His-tagged version at ~36 kDa in which the full-
length recombinant protein has been translated; and a band at ~42 kDa corresponding to 
glycosylated RDH12.   mAb 2C9 also recognized RDH12 as an ~33-kDa protein on 
immunoblots of lysates of human retinas but not RPE/choroid. (Figure 3-2B and 3-3L). 
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However, mAb 2C9 only recognized the human RDH12, and failed to recognize the 
mouse ortholog (Figure 3-2C).  
Rabbit polyclonal antibodies rAb CSP and rAb CKR were elicited by 
immunization with synthetic peptides corresponding to 252-SPFFKSTSQGAQ-263 and 
285-CKRMWVSSRARNKKT-299 of the mouse Rdh12 sequence, respectively. These 
antibodies possessed similar affinities for mouse Rdh12, and did not display cross-species 
reactivity with the human ortholog (Figure 3-2C). 
RDH12 immunolocalization in mice and humans 
To determine localization of Rdh12 expression in mouse eyes, 
immunohistochemical analysis was performed with both rAb CSP and rAb CKR. Each 
antibody showed similar immunoreactivities in wild-type retina/RPE/choroid 
cryosections that were absent in Rdh12–/– mice (shown for rAb CSP antibody in Figure 
3-3A to K). The signal in the case of all anti-RDH12 antibodies (anti-mouse or anti-
human) was sensitive to paraformaldehyde fixation, with optimal staining achieved with 
sections fixed for short times (30 min) or without paraformaldehyde (e.g., with cold 
methanol). 
The pattern of Rdh12 immunoreactivity present in mouse retina/RPE/choroid 
sections was consistent with expression in the photoreceptor IS and outer nuclear layer 
(ONL), with no apparent expression in the RPE or photoreceptor OS (Figure 3-3A to D). 
Double-labeling experiments using rhodopsin antibodies specific for the rod OS (Figure 
3-3E to G) and PNA-lectin staining of cone sheaths (Figure 3-53 to K) showed no 
overlap with Rdh12 immunoreactivity. 
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For localization of RDH12 expression in human eyes, the mouse mAb 2C9 was 
used. As in the mouse, the pattern of mAb 2C9 immunoreactivity in human eyes was 
consistent with RDH12 expression in photoreceptor IS and the ONL (Figure 3-3N), with 
no evidence of overlap with rhodopsin expression in the rod OS (Figure 3-3O), with 
PNA-lectin labeling of cone sheaths (Figure 3-5P), or with RDH8 expressed in rod and 
cone OS (Figure 3-3Q) [55]. 
The similar localization of Rdh12 and RDH12 proteins in mouse and human 
photoreceptors, respectively, may indicate an analogous physiological role of the 
enzymes in both species and suggests that the Rdh12–/– mouse is likely to recapitulate, at 
least in part, deficits resulting from RDH12 loss-of-function mutations in humans. 
Rdh12 localization in dark- and light-adapted mouse retina 
To determine whether RDH12 undergoes light-induced movements similar to the 
translocation of other photoreceptor proteins (46), we compared the pattern of Rdh12 
immunoreactivity in retinas of wild-type albino mice that were dark-adapted or exposed 
to bleaching light (2000 lux for 2 h) (Figure 3-4). Under conditions resulting in 
redistribution of transducin from photoreceptor OS in the dark to IS in the light, Rdh12 
immunoreactivity remained confined to the IS. Similar results were obtained for wild-
type pigmented mice, in which bleaching was less efficient (data not shown). 
Retinal histology of Rdh12–/– mice 
Light micrographs of retina/RPE/choroid sections from Rdh12–/– and wild-type 
mice showed comparable retinal histology at 7 months of age (Figure 3-5A and B), with 
normal lamination, numbers of cells, and apposition with the RPE. Similarly, 
transmission electron micrographs at 7 months of age revealed no major differences in 
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retinal architecture or in the ultrastructure of photoreceptor OS and IS, nor of the ONL 
(Figure 3-5C and D). There was no evidence of accumulated bone spicule pigment, 
photoreceptor debris, retinyl ester droplets, retinal detachment, or altered ratios of rods to 
cones. Although the thickness of the ONL did not appear to be decreased at 10 months of 
age, morphometric analysis showed slightly decreased OS-plus-IS lengths in the inferior 
retinas of Rdh12–/– animals (Figure 3-5E and F). 
Analysis of oxidative stress in Rdh12–/– mice 
Indicators of oxidative stress were assayed in retinas from Rdh12–/–, Rdh12+/–, 
and wild-type mice subjected to bleaching light (5,000 lux for 30 min) before being 
sacrificed. Levels of lipid peroxidation products present in retinal homogenates, assayed 
as TBARs, were not significantly increased due to Rdh12 loss-of-function (Figure 3-6A). 
In addition, transcript levels for HO-1, an enzyme that is upregulated in response to 
oxidative stress, were not markedly increased (Figure 3-6B) [200]. Thus, despite the 
ability of RDH12 to recognize C9 aldehydes resulting from lipid photooxidation, our data 
do not indicate that Rdh12 is unique in counteracting oxidative stress in the retina, at least 
in the short term [136]. 
Retinoid analysis with Rdh12–/– mice 
To assay the steady-state function of the visual cycle, HPLC analysis was used to 
compare the retinoid content of whole eyes from Rdh12–/–, Rdh12+/–, and wild-type 
mice that were dark adapted or light adapted and subjected to intense bleaching light 
(5,000 lux for 20 min), or subjected to bleaching and allowed to recover in the dark (30 
min). Under dark-adapted and light-adapted conditions, the retinoid content of eyes from 
Rdh12–/– and wild-type animals were equivalent and unaffected by the Leu450Met 
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polymorphism of Rpe65. In all cases, 11-cis retinal predominated in the dark-adapted 
state, and all-trans retinal and all-trans retinol predominated in the light-adapted state, 
with no significant differences between genotypes (Figure 3-7A). In addition, there were 
no significant differences in retinyl ester content between Rdh12–/– and wild-type 
animals, with low levels of all-trans retinyl esters present in the dark- and light-adapted 
states that increased upon bleaching (data not shown). However, the Rpe65 genotype was 
a major factor in determining rates of 11-cis retinal regeneration during recovery in the 
dark after bleaching for both Rdh12–/– and wild-type mice. In both cases, recovery in 
Rpe65-Leu450/ Rpe65-Leu450 (L/L) and Rpe65-Leu450/ Rpe65-Met450 (L/M) animals 
was significantly faster than that in Rpe65-Met450/ Rpe65-Met450 (M/M) animals (data 
not shown). We therefore excluded the last genotype in such comparisons and found that 
11-cis retinal, all-trans retinal, and all-trans retinol contents were equivalent in eyes from 
Rdh12–/– and wild-type animals that were subjected to bleaching and allowed to recover 
in the dark for 30 min (Figure 3-7). 
 
Discussion 
Mutations in human RDH12 cause a severe form of childhood onset arRD 
associated with massive accumulation of bone spicule pigment, RPE atrophy, and 
macular scarring [106, 137, 138]. Young children possess visual function, whereas the 
condition progresses to legal blindness in early adulthood. RDH12 activity has been 
proposed to be necessary for the recovery phase of the visual cycle on the basis of in vitro 
studies showing that recombinant RDH12 efficiently converts all-trans retinal to all-trans 
retinol and that RDH12 transcripts are present in the ONL in monkey and mouse retinas 
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[135, 136] . In this case, it follows that RDH12 loss-of-function mutations should 
decrease visual cycle efficiency, potentially resulting in reduced 11-cis retinal synthesis 
and the buildup of potentially toxic aldehyde intermediates in the retina.  
Rdh12–/– mice kept in a regular light-dark cycle did not develop any histological 
signs of retinal degeneration within the first 10 months of life, as assessed at the light 
microscope or ultrastructural level. Analysis of ocular retinoids showed no significant 
differences in 11-cis retinal content or rates of recovery following exposure to full 
bleaching light, with no accumulation of all-trans retinal or other aldehydes potentially 
resulting from lipid peroxidation [136]. In addition, an enzyme marker of oxidative 
stress, heme oxygenase 1, was not upregulated. Electroretinogram (ERG) analysis, 
performed by Klaus Rüther of Augenklinik Campus Virchow-Klinikum Charité (Berlin, 
Germany) showed only minor alterations in responses in the dark-adapted state or for 
recovery after bleaching in both young and old animals [200, 204]. In addition, we found 
that RDH12 expression localizes to the photoreceptor IS and the ONL in both mouse and 
human retinas and is not present in OS, where phototransduction takes place.  This 
expression pattern is similar to that reported for RDH11 and contrasts with those reported 
for DHRS3 and RDH8, as present throughout cone cells and in rod OS, respectively [54, 
55]. Further, we found no evidence of light-induced translocation of Rdh12 within the 
photoreceptors. 
Our analysis of the ocular phenotype of Rdh12–/– mice showed much less severe 
consequences than associated with human RDH12 mutations. The findings that Rdh12–/– 
mice retain nearly normal visual cycle throughput and that expression of the Rdh12 
protein is confined to photoreceptor IS are consistent with at least two different 
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interpretations. The first is that RDH12 activity is not essential for regeneration of the 11-
cis retinal chromophore in mice or humans and, instead, functions in an unrelated aspect 
of photoreceptor physiology not addressed by our studies. In this case, the absence of a 
rapid retinal degeneration phenotype in Rdh12–/– mice could be due to species 
differences related to retinal physiology, compensation of Rdh12 loss-of-function by 
another RDH isoform, or disease onset linked to time in years rather than relative age, a 
notion consistent with the mild pathology observed in very young children that 
progresses to devastating retinal degeneration over the course of approximately 20 years. 
A second possibility is that RDH12 activity is normally required for visual cycle 
function but that another RDH isoform can compensate for loss-of-function in mice, but 
not in humans. Such a scenario has been proposed for RDH5, as human mutations result 
in fundus albipunctatus but Rdh5–/– mice do not exhibit the flecked retinas or ERG 
responses characteristic of the disease [75]. Expression of RDH12 in photoreceptor IS, 
but not OS, would require that reduction of all-trans retinal occur at a site distant from its 
release from bleached photopigments, potentially involving a novel trafficking 
mechanism. Although it is somewhat counterintuitive, perhaps the dual-substrate 
specificity of RDH12 necessitates this compartmentalization in order to protect 11-cis 
retinal from reduction in the OS. 
Although analysis of the retinal phenotype of the Rdh12–/– mouse does not yet 
permit us to distinguish between these two alternatives, several pieces of evidence 
support the notion that RDH12 function is analogous in both mouse and human retina.  
The general pattern of RDH expression in the retina is similar, with Rdh12 localizing to 
the photoreceptor IS and Rdh8 localizing to the OS.  Microarray expression profiling of 
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photoreceptor cells during development shows that Rdh12 expression in the mouse is 
upregulated between postnatal days 6 and 10, corresponding to the time the OS are 
elaborated, and expression is dramatically downregulated in mice deficient in Nrl, a 
transcription factor required for the differentiation of rod precursor cells [17, 188, 205, 
206]. 
Additionally, it is clear that the outcomes of RDH12 and RPE65 loss-of-function 
are fundamentally different, with mutations in the latter resulting in uniformly severe 
functional deficits in canines, mice, and humans [67, 207, 208]. In addition, the genetic 
background of Rdh12–/– mice with respect to an Rpe65 polymorphism (Leu450Met) that 
affects rates of 11-cis retinal synthesis is a major factor that needs to be controlled for in 
comparisons of visual performance and visual cycle activity in Rdh12–/– versus wild-
type mice. In fact, consideration of the Rpe65 genotype is also likely to be important for 
studies of other visual cycle genes, especially other RDH isoforms, but has not always 
been done in previous studies of the effects of Rdh5, Rdh11, and Rdh8 loss-of-function 
on specific in vivo functional roles. 
Our understanding of RDH12 in vivo function is likely to be improved by 
developing appropriate challenges of the relevant physiological pathway(s) in knockout 
mice. This approach has proven successful in eliciting profound phenotypes in a number 
of strains of knockout mice in which no or mild differences from the wild-type were 
initially observed [209]. Mice deficient in multiple RDHs may also be useful for 
identifying a minimal set of isoforms that contribute to visual cycle function. Identifying 
the functional correlates between the Rdh12–/– mouse phenotype and human disease will 
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be critical for establishing an animal model useful for evaluating potential modes of 
therapeutic intervention. 
 
Outside Contributions: Ingo Kurth and Christian Hübner generated anti-mouse Rdh12 
antibodies and captured preliminary confocal images of immunolocalization in the 
mouse.  Klaus Rüther performed the ERG analysis.  Kecia Feathers performed the 
oxidative stress assays and assisted in the immunoassays.  Christina McHenry performed 




Figure 3-1. Construct design for the generation of Rdh12–/– mice. An Rdh12-carrying 
clone isolated from a 129/SvJ mouse genomic λlibrary (Stratagene) was used to construct 
the targeting vector. A 12.9-kb XmaI/NotI fragment including exons 1 to 5 of the Rdh12 
gene was cloned into the pKO-V901 plasmid (Lexicon Genetics) with a 
phosphoglycerate kinase gene (pgk) promoter-driven diphtheria toxin A cassette. A pgk 
promoter-driven neomycin resistance cassette flanked by loxP sites was ligated into the 
ApaI site in intron 3. A third loxP site and an additional EcoRV site were inserted into the 
BstBI site in the 5' region of the Rdh12 gene. The construct was electroporated into R1 
mouse embryonic stem (ES) cells. Neomycin-resistant clones were analyzed by Southern 
analysis, using an external, ~300-bp probe to screen for an additional EcoRV site 
incorporated into the targeted allele. Correctly targeted ES cells were transfected with a 
plasmid expressing Cre recombinase to remove the neomycin cassette and exons 1 to 3. 
Two independent embryonic stem cell clones were injected into C57BL/6 blastocysts to 




Figure 3-2. Development of anti-RDH12 antibodies. A: Schematic of human and 
mouse RDH12 amino acid sequence. RDH12 antigenic index calculated using the 
Jameson-Wolf prediction in the DNASTAR program Protean. Positions of synthetic 
human RDH12 peptides 1-3 corresponding to the 3 sequences of highest predicted 
antigenicity are shown underlined in the enlarged section.  The synthetic mouse Rdh12 
peptides used to generate the rabbit polyclonal antibodies. B, C:  Western blot analysis of 
anti-RDH12 antibodies.  mAb 2C9 is specific towards recombinant human RDH12, but 
not RDH11 or DHRS3.  C, mAb 2C9 detects a corresponding band in human retina 
lysates but not in human RPE or mouse tissue. rAb CSP detects a band in mouse retina 





Figure 3-3. RDH12 localizes to photoreceptor inner segments. Cryosections of wild-
type (A, B, and E to K) and Rdh12–/– (C and D) eyes are shown. (B, D, and E to K) 
Murine sections were counterstained with TOTO-3 to label cell nuclei, shown in blue. (M 
to Q) Cryosections of human eyes. (A, C, and M) Phase-contrast microscopy images. (D) 
Absence of Rdh12 staining in tissue from Rdh12–/– mice confirms the specificity of the 
antibody. Rdh12 labeling (green) did not colocalize with rhodopsin (red) (E to G) or 
PNA-lectin (red) (H to K). (L) A monoclonal antibody directed against human RDH12 
detects a corresponding band in retina lysates but not in RPE. (N) In the human retina, 
RDH12 localizes to photoreceptor inner segments as well and does not overlap with (O) 
rhodopsin, (P) PNA-lectin, or (Q) Rdh8. OS, outer segments; ONL, outer nuclear layer; 
IS, inner segments; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion 






Figure 3-4. Rdh12 immunolocalization dark-adapted and light-adapted mouse 
retina. Wild-type albino mice were maintained in darkness overnight or exposed to 2000 
lux fluorescent white light for 2 h. Retina/RPE/choroid cryosections were incubated with 
primary antibody specific for mouse Rdh12 or transducin, and then with streptavidin-
AlexaFluor-488 (green) and -555 (red), respectively. DAPI (blue) was used to label cell 
nuclei. Sections were imaged using fluorescence confocal microscopy. D.A., dark-
adapted; L.A., light-adapted. OS, outer segments; IS, inner segments; ONL, outer nuclear 
layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; 






Figure 3-5. Retinal histology and thickness measurements for Rdh12–/– versus wild-
type mice. (A and B) Semithin sections of Rdh12–/– and wild-type retinas/RPE/choroid 
stained with methylene blue. (C and D) Transmission electron micrographs of 
photoreceptor inner segments in Rdh12–/– and wild-type mice at 7 months of age. (E and 
F) Plots of photoreceptor layer and total retinal thicknesses for Rdh12–/– and wild-type 
mice, with measurements made on sections parallel to the vertical meridian of the eye 
and with standard deviations shown. ●, wild-type; ▲
  
Rdh12–/–. OS, outer segment; IS, 





Figure 3-6. Analysis of oxidative stress in Rdh12–/– mice. (A) Comparison of TBARs 
in retinal homogenates as an index of lipid peroxidation and oxidative stress. (B) Assay 
of HO-1 expression using quantitative real-time PCR with retinal cDNAs, with transcript 






Figure 3-7. Retinoid content of eyes from Rdh12–/– mice. (A) Retinoid content given 
in absolute amounts. (B) HPLC analysis of retinoids extracted from eyes from (I to III) 
wild-type (Rdh12+/+) and (I' to III') Rdh12–/– mice that were (I) dark adapted, (II) 
bleached (5,000 lux for 10 min), or (III) bleached and allowed to recover (5,000 lux for 
10 min, dark for 30 min). Retinaldehydes were extracted as syn- and anti-retinal oximes 
and summed. 1, syn-11-cis retinal oxime; 2, syn-all-trans retinal oxime; 3, anti-11-cis 





CHAPTER 4  
 





RDH12 is a major disease gene for Leber congenital amaurosis (LCA), with 
RDH12 mutations responsible for ~2% of cases of childhood-onset severe autosomal 
recessive retinal dystrophy [106, 137, 138, 210]. These individuals experience poor 
vision in early life that progressively declines with age as a result of both rod and cone 
degeneration [211]. Analyses of retinal organization and visual function in patients with 
mutations in RDH12 or RPE65, another LCA gene involved in retinoid metabolism, show 
distinctly different pathologies associated with defects in each gene that will be important 
to consider when developing targeted forms of therapy [212]. 
RDH12 encodes a member of the family of short chain dehydrogenases/reductases 
(SDRs) that catalyze oxidation and reduction reactions involved in various aspects of 
metabolism (reviewed in Refs. [213] and [214]). In the photoreceptor cells and retinal 
pigment epithelium (RPE), the interconversion of oxidized and reduced retinoids by 
retinol dehydrogenase/reductase (RDH) enzymes is an important feature of the visual 
cycle, the process responsible for the conversion of vitamin A (all-trans retinol) to 11-cis 
retinal, the chromophore of the visual pigments (reviewed in [215]). On the basis of in 
                                                 
‡ Portions of this chapter were published in:   
Chrispell JD, Feathers KL, Kane MA, Kim CY, Brooks M, Khanna R, Kurth I, Hübner CA, Gal A, Mears 
AJ, Swaroop A, Napoli JL, Sparrow JR, Thompson DA. Rdh12 activity and effects on retinoid processing 
in the murine retina. J Biol Chem. 2009 Aug 7;284(32):21468-77. 
77 
 
vitro assays showing reactivity toward retinaldehyde substrates and expression in 
photoreceptor cells, RDH12 was initially proposed to function in the reduction of all-
trans retinal released by bleached visual pigments [135]. Subsequent in vitro studies 
showed that RDH12 also acts upon C9 aldehydes resulting from lipid photo-oxidation, as 
well as certain steroid substrates, suggesting that it may contribute to additional pathways 
important for photoreceptor function [136, 139, 140, 216]. In previous studies, we 
generated Rdh12-deficient mice and evaluated their retinal phenotype, finding grossly 
normal retinal histology, visual responses, retinoid content, and assays of oxidative stress 
[204]. We also showed that RDH12 localizes to photoreceptor inner segments (IS) in 
both humans and mice, distant from the phototransduction reactions occurring in the 
outer segment (OS) disc membranes. Based on this analysis, we concluded that RDH12 
deficiency does not limit chromophore synthesis or visual cycle throughput, in agreement 
with Maeda et al. [217]. 
Earlier attempts to identify an RDH isoform essential for chromophore synthesis 
also failed to do so. These studies included generation and analysis of Rdh5-deficient 
mice lacking the RDH isoform specific to the RPE, Rdh11-deficient mice lacking the 
RDH isoform most closely related to Rdh12, and Rdh8-deficient mice lacking the RDH 
isoform that localizes to photoreceptor OS [56, 73, 74, 142]. In each case, loss-of-
function resulted in only minor slowing of dark adaptation without retinal degeneration, 
raising the possibility of redundancy in RDH function relative to the visual cycle 
mechanism. 
In this chapter, we show that the retinas of Rdh12-deficient mice exhibit a 
markedly decreased capacity to reduce retinaldehyde substrates in vitro but do not exhibit 
78 
 
decreased synthesis of 11-cis retinal in vivo. Our data are consistent with a mechanism in 
which RDH12 contributes to the reduction all-trans retinal that escapes conversion to all-
trans retinol by enzyme(s) present in the OS. Although fundamental differences exist 
between species, our findings in mice point to an important role of RDH12 in retinoid 
metabolism occurring in photoreceptor cells, and of likely relevance to disease pathology 
in the human retina, but that does not limit chromophore synthesis in vivo. 
 
Materials and Methods 
All experimental procedures complied with the regulations of the University of 
Michigan Committee on Use and Care of Animals and the ARVO Statement for the Use 
of Animals in Ophthalmic and Vision Research.  Mice were reared in a 12 h-12 h light-
dark cycle (~800-lux room light, as indicated below) and euthanized by CO2 inhalation. 
Animals and antibodies 
Transgenic mice of the following genotypes were used for our studies: Rdh12−/− 
mice homozygous for a Rpe65-Leu450 (L/L) or Rpe65-Met450 (M/M) polymorphism on 
a mixed Sv129;C57BL/6 (pigmented) background (15); Rdh12−/− mice on the BALB/c 
(albino) background and homozygous for Rpe65-Leu450 (L/L) that were obtained by 
breeding (generation F6); Rdh12−/− mice heterozygous for a Sod2 null allele (Sod2+/−) 
and homozygous for Rpe65-Met450 (M/M) obtained by breeding with mice from The 
Jackson Laboratory (Bar Harbor, ME; stock No. 002973, strain B6.129S7-Sod2tm1Leb); 
Rdh11−/− mice homozygous for Rpe65-Leu450 (L/L) (pigmented) characterized by P. 
Nelson and K. Palczewski [73]; and Nrl−/− mice homozygous for Rpe65-Met450 (M/M) 
that have a model “all-cone” retina [17](21). Primary antibodies used were: a rabbit anti-
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Rdh12 polyclonal antibody specific for the mouse protein (rAb CSP) [204]; a rabbit anti-
transducin polyclonal antibody (Genetex); and a rabbit anti-arrestin polyclonal antibody 
(Affinity Bioreagents). 
Analysis of visual cycle retinoids 
All-trans retinal, all-trans retinol, and 11-cis retinal levels in mouse eyes were 
determined using normal-phase high performance liquid chromatography (HPLC) as 
described previously [138]. In brief, dark-adapted mice (∼3 months old) were subjected 
to bleaching light (5000 lux, 15 min), recovered in the dark for 0–60 min, and euthanized. 
Under dim red light, whole eyes were homogenized in chloroform:methanol: 
hydroxylamine, the organic phases were collected, and the solvent evaporated. The 
extracts were dissolved in hexane and chromatographed on a Supelcosil LC-31 analytical 
column (25 cm × 4.6 mm, 5 μm) developed with 95% hexane, 5% 1,4-dioxane. 
Absorbance peaks were identified by comparison with external standards, and molar 
quantities per eye were calculated by comparison with standard concentrations 
determined spectrophotometrically using extinction coefficients (Chapter 3) and 
normalizing to total sample volumes [199]. Retinaldehyde content was calculated as the 
sum of syn- and anti-retinal oximes. Data were analyzed and curves fitted using 
SigmaPlot (Systat Software Inc.). Standards used were: all-trans retinol (Sigma Aldrich), 
11-cis retinol obtained by NaBH4 reduction of 11-cis retinal (R. Crouch), and all-trans  






Analysis of retinal reductase activity 
Mouse retina homogenates were assayed for retinal reductase activity with 
exogenous substrates. Light-adapted mice (∼2–5 months old) were euthanized, and 
dissected retinas from 4–8 animals were pooled and homogenized in 300 μl of 0.25 M 
sucrose, 25 mM Tris acetate, pH 7, 1 mM dithiothreitol. The homogenates were 
centrifuged at 1000 × g for 5 min to remove unbroken cells, and then the supernates were 
sonicated with a microtip probe (30 times for 1 s) on ice. Protein concentrations were 
determined by a modification of the Lowry procedure, and levels of Rdh12 and arrestin 
(a marker for total photoreceptor proteins) were evaluated by densitometric analysis of 
Western blots [219]. Assay reactions (200 μl) were prepared that contained 20 μg of 
retinal protein, 200 μM all-trans retinal or 11-cis retinal, and 200 μM NADPH in HEPES 
buffer (pH 8); reactions were incubated for 0–60 min at 32 °C (a reaction temperature 
that minimizes thermal isomerization of the retinoid substrates, as well as enzyme 
inactivation). All-trans retinol and 11-cis retinol formation were quantitated using 
normal-phase HPLC analysis with comparison to standards, as described above, and the 
data were analyzed using SigmaPlot. Controls for recovery included samples containing 
known amounts of standard compounds [138]. 
Analysis of histology and retinal thickness 
Anesthetized mice were perfused, and the eyes were enucleated, post-fixed for at 
least 1 h in 4% paraformaldehyde or 2% paraformaldehyde plus 2% glutaraldehyde, and 
embedded in JB-4 plastic. Sections (5 μm) were stained with Lee's stain and imaged on a 
Nikon Eclipse E800 microscope with Nikon DMX1200 digital camera using the 
manufacturer's data acquisition software. Measurements of retinal outer nuclear layer 
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(ONL) thickness on sections parallel to the vertical meridian of the eye were plotted 
versus distance from the optic nerve head for animals of various ages [220]. 
Analysis of transcript abundance by quantitative real-time PCR 
Total RNA was isolated from mouse retinas (∼2–3 months old) using the RNeasy 
mini kit (Qiagen), and quality and quantity were assessed using an Agilent Bioanalyzer 
2100. First strand cDNAs were generated using SuperScript II (Invitrogen) and oligo(dT) 
(Invitrogen). Sequences present in the 3′-untranslated regions of transcripts of interest 
were amplified using AmpliTaq Gold (Applied Biosystems) and SYBR Green I 
(Molecular Probes) with a Rotor-Gene3000 thermocycler (Corbett Research) as follows: 
95 °C for 10 min, 95 °C for 25 s, 57 °C for 25 s, and 72 °C for 30 s, with steps 2–4 
repeated 35 times. Samples in triplicate were each amplified in triplicate and normalized 
to the values for Hprt transcripts. Primers (sense, antisense) were as follows: Rdh12, 5′-
GGCCAATCTGCTCTTCACTC-3′, 5′-ACTTTCCACTCAGGGGCTCTA-3′; Rdh11, 5′-
CCACAGCAAACTAGCCAACA-3′, 5′-CCAACTGGCAATCACTGAAA-3; Rdh8, 5′-
GATGTGGCCCAGGTCATT-3′, 5′-GACCAAGGTTGAGGAGGTGA-3′; Hprt, 5′-
GCAAGCTTGCTGGTGAAAGGA-3′, 5′-CCTGAAGTACTCATTATAGTCAAGGG-
3′. 
Microarray analysis of expression 
Total retinal RNA from Rdh12−/− and wild-type mice (∼2 months old) was 
isolated as described above and converted into biotinylated, fragmented, and cleaned 
cRNA using Affymetrix reagents. Mouse genome arrays (Affymetrix 430_2.0) were 
hybridized with fragmented cRNA and processed as described (34). The arrays were 
optically read with a Hewlett-Packard GeneArray scanner, and CHP/.CEL files were 
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generated using the Affymetrix microarray suite of programs. The quality of the 
GeneChip hybridizations was excellent according to Affymetrix criteria. Normalization 
and calculation of signal intensities were performed using the Robust Multi-Chip 
Average software package (R-Project). Ratios of average signal intensity (log 2) were 
calculated for probe sets between pairs of genotypes and converted to average fold 
change. Statistical validation was performed as described previously by assigning p- 
values and fold changes of gene responses in a two-step procedure based on the 
construction of false discovery rate confidence intervals [221-223]. Affymetrix GeneChip 
data for flow-sorted GFP+ photoreceptor cells from wild-type and Nrl−/− mice at 
various developmental ages were generated as described previously [205]. 
 
Results 
Visual cycle retinoids in Rdh12-deficient mouse eyes 
The first step in the recycling aspect of the visual cycle is the conversion of all-
trans retinal released from bleached visual pigments to all-trans retinol that is returned to 
the RPE. In studies employing retinoid extraction and HPLC analysis, we showed 
previously that steady-state levels of visual cycle retinoids were similar in the eyes of 
Rdh12-deficient and wild-type mice heterozygous for the Rpe65-Leu450Met (L/M) 
polymorphism that impacts rates of chromophore synthesis [204]. We have now used 
these methods to evaluate retinoid processing during dark adaptation in Rdh12-deficient 
mice homozygous for the Rpe65-Leu450 (L/L) variant associated with high visual cycle 
throughput [132]. During recovery in the dark after full bleaching, our results show that 
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rates of all-trans retinal reduction and 11-cis retinal formation are not significantly 
different between Rdh12−/− and wild-type animals (Figure 4-1). 
RDH activity in Rdh12-deficient mouse retinas 
To determine the contribution of Rdh12 to the overall capacity of the mouse 
retina to reduce retinaldehyde substrates, we performed in vitro assays of retinal 
homogenates with exogenous all-trans retinal or 11-cis retinal as substrate. Retinas from 
Rdh12−/− and wild-type mice on three different genetic backgrounds were evaluated: 
Rpe65-L/L or Rpe65-M/M on 129Sv:C57BL/6 (pigmented) and Rpe65-L/L on BALB/c 
(albino). For wild-type pigmented and albino mice that were Rpe65-L/L, we found that 
robust retinal reductase activity was present in assays with saturating levels of all-trans 
retinal or 11-cis retinal (Figure 4-2A and C). Initial rates of all-trans retinol formation 
were 0.51 and 0.62 pmol min−1 μg protein−1 in the pigmented and albino mice, 
respectively. Similarly, initial rates of 11-cis retinol formation were 0.70 and 0.60 pmol 
min−1 μg protein−1. For Rdh12−/− mice, significantly lower retinal reductase activity was 
observed with both substrates (Figure 4-2A and C). Initial rates of all-trans retinol 
formation were 0.052 and 0.057 pmol min−1 μg protein−1 in pigmented and albino mice, 
respectively, whereas 11-cis retinol formation was undetectable. Mice on the Rpe65-M/M 
background exhibited lower RDH activity than Rpe65-L/L mice; however, the relative 
decrease in RDH activity seen in Rdh12−/− mice was similar (Figure 4-2B and D). 
RDH activity in Rdh11-deficient mouse retinas 
In vitro assays of retinal homogenates from Rdh11−/− mice exhibited retinoid 
reductase activity that was significantly greater than of Rdh12−/− mice on the same 
genetic background (pigmented Rpe65-L/L) (Figure 4-3). At saturating substrate 
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concentrations, initial rates of all-trans retinol and 11-cis retinol formation in Rdh11−/− 
retinal homogenates were 0.57 and 0.99 pmol min−1 μg protein−1, respectively. 
Rdh12 expression on various genetic backgrounds and during development 
To determine whether Rdh12 expression reflects differences in visual cycle 
efficiency attributable to the Rpe65-L450M polymorphism, we used quantitative real-
time PCR to compare transcript levels in eyes from pigmented wild-type mice that were 
Rpe65-L/L or Rpe65-M/M. We found that Rdh12 transcripts were ∼4-fold lower in mice 
with the Rpe65-M/M polymorphism associated with low levels of 11-cis retinal 
synthesis, compared to mice with Rpe65-L/L, associated with high levels of 11-cis retinal 
synthesis (Figure 4-4A). In Nrl-deficient mice having an ‘all-cone’ retina, Rdh12 
transcript levels were approximately 10-fold lower than in wild-type mice (Rpe65-M/M) 
(Figure 4-4B). Changes of the same magnitude were not seen for Rdh11.  
To evaluate Rdh12 expression during development, data from microarray analysis 
of flow-sorted GFP-positive photoreceptor cells were obtained as described previously 
[205]. The photoreceptor cells were from dissociated retinas of transgenic mice 
expressing GFP under the control of the Nrl promoter on the wild-type (predominantly 
rod) or the Nrl−/− (all-cone) background (Rpe65-M/M). Plots of normalized signal 
intensity showed that Rdh12 transcript levels markedly increased from embryonic day 16 
to postnatal day 28 in wild-type mice and to a lesser extent in Nrl−/− mice (Figure 4-4C). 






Expression of RDH isoforms in wild-type and Rdh12-deficient mice 
The absence of retinal pathology in Rdh12-deficient mice suggests, as one 
possibility, that one or more RDH isoform(s) with overlapping activity compensates for 
Rdh12 loss-of-function. To compare the expression of RDH isoforms in Rdh12−/− and 
wild-type mice (Rpe65-L450M) in total retinal RNA, relative transcript abundance was 
evaluated using Affymetrix microarray profiling. For each of the RDH isoforms reported 
to be present in photoreceptor cells and represented on gene chips (Rdh11, Rdh13, Rdh14, 
Dhrs3), we found no marked differences in expression between the Rdh12−/− and wild-
type mice (Table 4-1) [54, 135]. This was also the case for Rdh10 expressed in RPE and 
Müller cells, as well as other known RDH isoforms, including Rdh1, Rdh7, Rdh9, and 
Rdh16 (data not shown) [147]. One exception was Rdh5, for which transcripts were 
apparently decreased ∼1.7-fold in Rdh12−/− mice. The presence of Rdh5 transcripts in 
our RNA preparations likely reflects the presence of contaminating RPE cells in our 
dissected retinal tissue, as Rdh5 is an RPE-specific enzyme involved in the conversion of 
11-cis retinol to 11-cis retinal [70]. A second exception was Rdh8, which localizes to 
photoreceptor OS. Because Rdh8 is not represented by probe sets on the Affymetrix gene 
chips, Rdh8 expression was evaluated using quantitative real-time PCR analysis, which 
showed that transcripts were decreased ∼3.1-fold in Rdh12−/− mice. The apparent 
down-regulation of Rdh5 and Rdh8 suggests that retinoid processing associated with 
visual cycle function is less robust in the absence of Rdh12. As no known RDH isoforms 
appear to be up-regulated in Rdh12−/− mice, our findings suggest that the activity 
provided by the enzyme levels normally present in mouse retina are sufficient to 
compensate for Rdh12 loss-of-function. 
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Effects of aging and oxidative stress in Rdh12-deficient mice 
To assess potential changes in retinal histology at advanced ages, we performed 
morphometric analysis of retina/RPE/choroid sections from Rdh12-deficient and wild-
type mice reared in normal laboratory lighting. We found no evidence of increased retinal 
pathology or decreased ONL thickness in Rdh12−/− mice at 20 months old that were 
pigmented and Rpe65-L/L or Rpe65-M/M (Figure 4-5A and B). We also evaluated the 
retinas of albino Rdh12−/− mice on the BALB/c background, which imparts increased 
light sensitivity due in part to the presence of the Rpe65-L450 polymorphism [131]. 
Again, no increased retinal pathology or decreased ONL thickness was seen in Rdh12-
deficient mice crossed onto the BALB/c background for six generations (Figure 4-5C). 
To determine whether increased oxidative stress exacerbates the retinal phenotype 
of Rdh12-deficient mice, we crossed mice carrying a null allele of the superoxide 
dismutase 2 gene (Sod2) with Rdh12−/− animals. Although the homozygous null 
Sod2−/− genotype is lethal, Sod2+/− mice are viable and exhibit increased levels of 
reactive oxygen species associated with increased oxidative damage to proteins, DNA, 
and membranes [224, 225]. Mice with the Rdh12−/−;Sod2+/− (Rpe65-M/M) genotype 
were obtained by breeding and were evaluated by morphometric analysis. Retina sections 
from Rdh12−/−;Sod2+/− mice at 9 months old showed no evidence of increased retinal 
pathology or decreased ONL thickness relative to age-matched Sod2+/− mice that were 
wild-type for Rdh12 (Figure 4-5D). In addition, the RDH activity of retinal lysates 
assayed in vitro was equivalent in Rdh12−/−;Sod2+/− and Rdh12−/− animals on the 





Our study establishes that Rdh12 loss-of-function markedly impacts the overall 
capacity of the mouse retina to reduce retinaldehyde substrates, even though in vivo rates 
of all-trans retinal reduction during recovery from bleaching are not significantly 
affected. The decrease in the ability of the Rdh12-deficient retina to reduce all-trans 
retinal and profound loss of activity toward 11-cis retinal suggest that Rdh12 makes a 
unique contribution to the capacity for retinoid processing in the photoreceptor cells. 
These findings are consistent with the assumption that defects in retinoid metabolism 
contribute to the disease phenotype resulting from RDH12 mutations in patients. 
Together with previous studies, our results suggest that the supply of all-trans retinol 
needed for chromophore synthesis is not limited by RDH activity in the photoreceptors 
and that this need may be met by delivery from the circulation and stores of retinyl esters 
in the RPE. It follows that increased rates of regeneration attributed to IRBP may result 
from a potential role in reducing photoreceptor levels of all-trans retinol, rather than from 
delivery of all-trans retinol to the RPE [56, 73, 74, 204, 217, 226]. 
Previous studies of the retinal phenotype of Rdh12-deficient mice did not detect 
marked changes in retinoid processing or visual cycle function [204, 217]. In one study, 
delayed recovery of the electroretinogram (ERG) a-wave after bleaching was observed as 
well as increased levels of 11-cis retinal, but no decrease in all-trans retinal reductase 
activity was detected in vitro [217]. Subsequent studies of Rdh12-Rdh8 double knockout 
mice showed that Rdh12 loss-of-function significantly decreased the all-trans retinal 
reductase activity of Rdh8-deficient mouse retinas [227]. In contrast, our studies show 
that retina homogenates from mice deficient in Rdh12 alone have significantly reduced 
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capacity for reduction of both trans- and cis retinaldehydes on all genetic backgrounds 
tested, but do not exhibit delayed dark adaptation or increased levels of retinaldehydes in 
vivo (this chapter and [204]). In addition, the decrease of retinal reductase activity in 
Rdh12-deficient mice is greater than that observed for Rdh11-deficient mice. We also 
found that wild-type mice with the Rpe65-M/M polymorphism exhibit lower levels of 
retinal reductase activity than mice with the Rpe65-L/L polymorphism, associated with 
higher visual cycle activity [131, 132]. In collaboration with the laboratory of Dr. Janet 
Sparrow at Columbia University, HPLC analysis of N-retinylidene-N-retinylethanolamine 
(A2E) and A2E isomers, the major fluorophores of lipofuscin granules associated with 
age-related macular degeneration present in posterior eyecups was performed. We 
observed that Rdh12-deficient mice exhibit elevated A2E levels regardless of background 
and that these levels increase with aging  Additionally, levels of A2E were lower in 
Rdh12−/− mice on the Rpe65-M/M background than in Rpe65-L/L animals, in agreement 
with earlier studies [217] (Figure 4-7). Thus, a key finding of our study is that Rdh12 
activity appears to correlate with visual cycle activity, with loss-of-function resulting in a 
shift in the equilibrium toward products that exit the visual cycle. As Rdh12 deficiency 
does not result in elevated levels of total retinaldehydes, such increases are likely to occur 
focally, transiently, or both. Although differing in mechanistic detail and degree of 
severity, the resulting accumulation of A2Es may reflect a situation akin to that due to 
mutations in ABCA4, which delay the removal of all-trans retinal from the disc 
membranes [49]. 
Retinoic acid synthesis involves the oxidation of retinaldehydes in a reaction 
typically catalyzed by members of the family of aldehyde dehydrogenase enzymes 
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(reviewed in [228]). Collaboration with Dr. Maureen Kane and the lab of Dr. Joseph 
Napoli at the University of California, Berkeley was established to assay levels of 
retinoic acid in retinal homogenates from dark-adapted mice using HPLC-coupled 
tandem mass spectrometry.   We found that retinoic acid levels were decreased in 
Rdh12−/− mice relative to the wild-type (Figure 4-8A).  In addition, significant 
decreases in total retinol content of retinas from Rdh12−/− mice were detected (Figure 4-
8B). These findings suggest that Rdh12 deficiency in the retina produces a shift in 
retinoid homeostasis resulting in decreased retinoid content.  This result was unexpected, 
as a previous study of recombinant RDH12 activity in vitro found increased levels of 
retinoic acid in transfected cells expressing loss-of-function mutants relative to cells 
expressing the wild-type protein [229]. This study suggests that RDH12 reduction of 
retinaldehydes is needed to protect against the potentially damaging effects of high levels 
of retinoic acid. However, our data do not support the view that RDH12 acts exclusively 
as a reductase in vivo to decrease levels of retinoic acid, as in vivo levels of both retinoic 
acid and total retinol were decreased in Rdh12−/− mice. The decrease in retinoic acid 
levels due to Rdh12 deficiency points to a complex mechanism involved in regulating 
retinoic acid biosynthesis, and suggests that RDH12 may play a role in this mechanism in 
the retina, either as a reductase or a dehydrogenase depending on its metabolic 
environment. Our findings further suggest that some aspects of the disease phenotype 
associated with human RDH12 mutations may be a consequence of impaired retinoic acid 
production and/or bioavailability. 
The broad substrate specificity of RDH12 has prompted suggestions that it 
functions in a number of various aspects of retinal cell biology. In vitro assays of 
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recombinant RDH12 activity have shown it can reduce certain lipid photo-oxidation 
products including the C9-aldehydes nonanal and 4-hydroxynonenal, as well as certain 
steroids including dihydrotestosterone, albeit with lower affinity and catalytic efficiency 
compared to all-trans retinal [136, 216]. In our initial analysis of the phenotype of 
Rdh12-deficient mice, we found no increase in oxidative products measured as 
thiobarbituric acid-reactive substances (TBARs) in the retina (Chapter 3 and [204]). We 
have now studied the retinal phenotype of Rdh12-deficient mice that were heterozygous 
for a null allele of manganese superoxide dismutase 2 (Sod2+/−). Mice heterozygous for 
Sod2 loss-of-function were used as model to test for effects of increased oxidative stress, 
as reduction of this enzyme activity results in increased mitochondrial oxidative damage 
and susceptibility to apoptotic cell death, whereas the Sod2−/− genotype is lethal and 
severe Sod2 deficiency alone results in profound retinal degeneration [224, 225, 230-
232]. Our results show no evidence of increased retinal cell death in Rdh12−/−;Sod2+/− 
mice, as measurements of ONL thickness and retinoid reductase activity were similar to 
those of Rdh12−/− mice on the wild-type background. Previous studies also reported 
increased apoptotic cell death in retinas of Rdh12-deficient mice exposed to high 
intensity illumination [217]. However, we detected no increase in age-related pathology 
in Rdh12−/− mice, including animals on the albino BALB/c background that were reared 
in normal laboratory lighting. Thus, while our findings do not rule out the possibility that 
RDH12 may play a role in protecting against oxidative stress and light-damage, they do 
not support the view that this is an exclusive function. 
Efforts to identify the RDH enzymes essential for visual cycle function have been 
confounded by the fact that photoreceptor cells express a number of isoforms which 
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exhibit the necessary specificity in vitro [54, 55, 135]. As no known RDH isoforms 
appear to be up-regulated in Rdh12−/− mice, our findings suggest that the activity 
provided by the basal levels of RDH activity present in mouse retina are sufficient to 
compensate for Rdh12 loss-of-function. Elegant studies of retinoid processing in retina 
slices and isolated photoreceptor cells have shown that all-trans retinol formation 
localizes to the OS during recovery from bleaching [233, 234]. Of the RDH isoforms 
known to be expressed in retina, only RDH8 has been localized to the OS [55, 227]. 
However, Rdh8-deficient mice exhibit only mild perturbations in retinoid processing in 
the form of decreased rates of dark adaptation, and no accompanying pathology [56]. 
Rates of dark adaptation are slightly decreased in Rdh12-Rdh8 double knockout mice and 
OS are shorter, but significant levels of chromophore synthesis persist [227]. These 
findings are consistent with recent measurements of in vivo rates of all-trans retinol 
synthesis suggesting that the rate-limiting step in the production of the 11-cis retinal 
chromophore is the release of all-trans retinal from opsin [226]. Thus, the primary role of 
RDH enzymes present in the photoreceptors may be to reduce potentially toxic levels of 
retinaldehydes in various cellular compartments. It seems possible that RDH8, which 
recognizes trans- but not cis-retinaldehydes, is important for the rapid reduction of all-
trans retinal in the vicinity of the rhodopsin signaling complex, whereas the contribution 
of RDH12, with its broader substrate specificity and localization near the metabolic 
source of NADPH, becomes more important under conditions of continuous illumination. 
As RDH12 is restricted to IS in both human and mouse retina and there is no evidence of 
light-induced translocation, this implies that all-trans retinal can move between outer and 
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IS compartments, perhaps associated with retinoid-binding proteins or with opsin found 
in the IS plasma membrane. 
In summary, our analysis of the retinal phenotype of Rdh12-deficient mice 
supports the view that defects in retinoid metabolism are a contributing factor to disease 
resulting from RDH12 loss-of-function mutations in patients, providing new insights into 
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Figure 4-1. All-trans retinal, 11-cis retinal, and all-trans retinol levels during 
recovery from bleaching. Rdh12−/− and wild-type mice were exposed to bleaching light 
(5000 lux, 15 min) and recovered in the dark for the times shown. Retinoids extracted 
from whole eyes in organic solvents were quantitated using normal-phase HPLC analysis. 
A, all-trans retinal; B, all-trans retinol; C, 11-cis retinal. Experimental values are plotted 







Figure 4-2. Effects of Rdh12 deficiency on in vitro retinoid reductase activity.  
Retinal homogenates were prepared from Rdh12−/− and wild-type mice that were 
homozygous for Rpe65-Leu450 (pigmented L/L) or Rpe65-Met450 (pigmented M/M) on 
the 129Sv:C57BL/6 background or for Rpe65-Leu450 (albino L/L) on the BALB/c 
background. The homogenates were incubated with exogenous retinaldehyde substrates 
(all-trans retinal or 11-cis retinal) and NADPH for various times, and retinol formation 
was quantitated by HPLC analysis of organic solvent extracts. Formation of all-trans 
retinol (A and B) and 11-cis retinol (C and D) in retinal lysates from Rdh12−/− and wild-
type mice is shown. A and C, time course (0–45 min). ○, Rdh12−/− (pigmented L/L); ▵, 
Rdh12−/− (albino L/L); ●, wild-type (pigmented L/L); ▴, wild-type (albino L/L). B and 
D, single point assays (60 min), except 11-cis retinol albino L/L (45 min). Open bars, 
Rdh12−/− mice; solid bars, wild-type mice. Assays were performed in triplicate and 






Figure 4-3. Effects of Rdh11 deficiency on in vitro retinoid reductase activity. Retinal 
homogenates from Rdh11−/− and wild-type mice (pigmented Rpe65-L/L) were assayed 
for RDH activity with exogenous retinoid substrates and NADPH for the times shown, 
and retinol formation was quantitated by HPLC analysis of organic solvent extracts and 
normalized to Rdh12 content. Assays were performed in triplicate and plotted as mean ± 
S.D. (n = 3). Data from Rdh11−/− mice (□) are shown alongside those from Rdh12−/− 






Figure 4-4. Comparative analysis of Rdh11 and Rdh12 expression in mouse retina. 
Quantitative real-time PCR was used to amplify RDH transcripts from retina total RNA, 
and cycle threshold data were normalized to Hprt and plotted as -fold difference. A, 
transcript levels in wild-type mice on the Rpe65-Met450 background compared with 
levels in wild-type mice on the Rpe65-Leu450 background (pigmented 110 days old; n = 
3). B, RDH transcript levels in Nrl−/− mice compared with levels in wild-type mouse 
(pigmented Rpe65-M/M, 50 days old; n = 3). C, expression during retinal development in 
Nrl−/− and wild-type mice. Normalized microarray intensity data for flow-sorted GFP+ 
photoreceptors isolated and analyzed as described in [205] is shown for following ages: 
embryonic day 16 (E16) and postnatal (P) days 2, 6, 10, and 28 (n = 4 for each time 





Figure 4-5. Retinal histology and ONL thickness in Rdh12−/− and wild-type mice at 
advanced age and on various genetic backgrounds. Anesthetized mice were perfused, 
and the eyes were enucleated, post-fixed for at least 1 h in 4% paraformaldehyde or 2% 
paraformaldehyde plus 2% glutaraldehyde, and embedded in JB-4 plastic [220]. 
Measurements of ONL thickness were obtained from plastic sections (5 μm) of Lee’s 
stained retina parallel to the vertical meridian of the eye and plotted vs. distance from the 
optic nerve head ± std. dev. (n=3). Phase contrast micrographs show representative Lee's 
stained retina/RPE/choroid sections (7 μm) from central retina. (A) Rdh12–/– and wild-
type (pigmented L/L; ~20 mo old). (B) Rdh12–/– and wild-type (pigmented M/M; ~20 
mo old). (C) Rdh12–/– and wild-type (albino L/L, ~6 mo old). (D) Rdh12–/– and wild-
type mice heterozygous for the Sod2 gene (pigmented M/M; ~9 mo old). Rdh12–/–, ○; 







Figure 4-6. Effects of increased oxidative stress on in vitro retinoid reductase 
activity. Retinal homogenates were prepared from wild-type, Rdh12−/−, and 
Rdh12−/−;Sod2+/– mice that were homozygous for Rpe65-Met450 (pigmented M/M) on 
the 129Sv:C57BL/6 background.  The homogenates were incubated with exogenous 
retinaldehyde substrates (all-trans retinal or 11-cis retinal) and NADPH for 60 min, and 
retinol formation was quantitated by HPLC analysis of organic solvent extracts. 
Formation of all-trans retinol (A) and 11-cis retinol (B) in retinal lysates is shown. 




Table 4-1. Microarray analysis of RDH isoforms expressed in mouse retina. 
Gene I.D. Probe Set Rdh12–/– vs. WT 
  -Fold change 
Rdh12 1424256_at -129.99 
Rdh11 1418760_at 1.29 
Rdh10 1426968_a_at -1.38 
Rdh13 1433799_at 1.15 
Rdh14 1417438_at 1.05 
Dhrs3 1448390_a_at -1.06 
Rdh5 1418808_at -1.68 
Rdh8a N.A. -3.15 
a Values obtained by qRT-PCR analysis. 
 
Rdh12−/− and wild-type mice (WT) were heterozygous for Rpe65-L450M. Data shown 
are the average chp/cel intensity of four replicates. For genes with multiple probes sets, 







Figure 4-7. A2E levels in Rdh12−/− and wild-type mice. Mouse posterior eyecups of 
Rdh12−/− and wild-type mice were extracted using organic solvent, and A2E levels (the 
sum of A2E and isoA2E) were quantitated using HPLC with comparison to standards. A, 
representative reverse-phase HPLC chromatograms obtained by monitoring at 430 nm. B, 
A2E levels in posterior eyecups at the ages indicated. Mice were C57BL/6 and 
homozygous for Rpe65-Leu450 (pigmented) unless noted, with M/M designating data 
from mice homozygous for Rpe65-Met450 and albino indicating mice that were BALB/c. 
□, Rdh12−/−; ■, wild-type; ▩, Rdh11−/−. Assays were plotted as mean ± S.E. for n > 3. 






Figure 4-8. Retinoic acid and total retinol content in Rdh12−/− and wild-type mice. 
Isolated retinas from dark-adapted mice were extracted with organic solvent under 
neutral and acidic conditions to obtain total retinol and retinoic acid-containing extracts, 
respectively, that were subjected to reverse-phase HPLC. A, retinoic acid was quantitated 
by coupled tandem mass spectrometry analysis. B, total retinol was quantitated using UV-
visible absorbance. Assays were plotted as mean ± S.E. for n = 3. □, Rdh12−/−; ■, wild-




CHAPTER 5  
 
DISCUSSION AND FUTURE DIRECTIONS 
 
This dissertation presents studies that further our understanding of RPE65 
structure and function and the role of RDH12 in retinoid processing within the retina.  
This work has led to the conclusion that RPE65 is localized solely to the RPE and not the 
retina in a number of rod- and cone-dominant species, limiting the likelihood of 
involvement in a cone-associated visual cycle.  In addition, while RDH12 was not found 
to be rate limiting in the visual response, RDH12-deficiency results in a decreased 
capacity of the retina for the reduction of retinaldehydes.  These findings give us better 
comprehension of the role that each enzyme plays in photoreceptor physiology, as well as 
in the pathogenesis associated with loss-of-function mutations in inherited retinal 
degeneration. 
RPE65 
When I began my studies in 2004, RPE65 had been characterized by our group as 
a disease gene responsible for a severe form of retinal dystrophy.  For the first time, this 
established a critical role for defects in RPE function in this class of diseases.  Our group 
as well as many others began characterizing RPE65 function and its role in pathogenesis 
and the visual cycle, with the ultimate goal of formulating targeted therapies to 
compensate for RPE65 dysfunction.  At the time, the role of RPE65 as the isomerase of 
the visual cycle was unknown, but RPE65 was known to be required for the synthesis of 
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the chromophore of the visual pigments, 11-cis retinal. Early studies suggested that 
RPE65 functions as a retinyl ester binding protein which interacts with other visual cycle 
proteins to present ester substrates to an unidentified retinoid isomerase.  RPE65 was also 
proposed to function in cone photoreceptors in an alternative chromophore regenerating-
pathway independent of the RPE. This proposal was based on reported expression of 
RPE65 transcripts in salamander cones and RPE65 protein in mammalian cones, but not 
in rod photoreceptors [94, 95].  These findings stood in contrast to others that addressed 
this issue in mice, showing RPE65 expression only in the RPE.   
Our goal in early studies was to identify RPE65 surface epitopes, assess protein 
interactions, and evaluate RPE65 expression in eyes from rod- and cone-dominant 
species using a monoclonal antibody approach. The antibody mAb 8B11, elicited using 
RPE membranes as immunogen, was generated before my arrival in the lab.  The 
corresponding antigenic determinant, KVNPETLETI, is highly conserved - making this 
antibody an effective tool for studies of RPE65 from a number of species. It is interesting 
to note that, in previous studies by others to develop RPE65 antibodies by immunization 
with synthetic peptides, the most effective antibody obtained was elicited by peptide 150-
NFITKVNPETLETIK-164 that contains the epitope recognized by mAb 8B11 (50). 
Antibodies recognizing this antigenic epitope were disseminated or replicated by the 
scientific community, and one such polyclonal antibody generated against a synthetic 
peptide corresponding to this epitope was utilized in the study showing RPE65 
expression to mammalian cones.   
To further pursue studies of RPE65 surface epitopes, protein interactions and 
localization within the retina, I set out to generate a second anti-RPE65 antibody (Chapter 
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2).  This monoclonal antibody recognized a predicted antigenic sequence in RPE65 that 
was not recognized by the ubiquitous antibodies currently employed by the field.  This 
antibody, mAb 1F9, recognized the epitope 312-FHHINTYEDNGFLIV-326.  While 
mAb 1F9 lacked the high affinity and extensive cross-species reactivity of mAb 8B11, 
both antibodies: 1) co-eluted RPE65 with RDH5 and no other visual cycle proteins (in 
agreement with previous studies); 2) localized to surface-exposed regions in the structural 
models generated via ab initio and comparative methods; and 3) displayed 
immunoreactivity only within the RPE and not the retina of the various rod- and cone-
dominant species tested.  This allowed us to conclude that the primary site of RPE65 
function is the RPE-based visual cycle.  While recent evidence points to very low levels 
of RPE65 expression in retina as assayed by qRT-PCR, it does not address potential 
contamination of retina samples with RPE cells due to their close biophysical association 
[235]. Our identification of two distinct RPE65 surface epitopes represented an initial 
step toward developing a structural understanding of this important disease gene product.  
A better understanding of the isomerization mechanism of retinyl esters by RPE65 will 
be critical to the design of future therapeutic measures, and only recently has the crystal 
structure of RPE65 been resolved [236]. 
RDH12 
Prior to my tenure in the laboratory, studies conducted by our group identified 
mutations in RDH12 associated with severe, early-onset autosomal recessive retinal 
dystrophy.  As one of the major interests of our group is the mechanism of the 
regeneration of the 11-cis retinal chromophore of the visual pigments vis-à-vis the visual 
cycle, this finding was particularly significant.  RDHs perform critical oxidation-
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reduction reactions in a number of pathways, including the visual cycle.  Early studies 
had shown that RDH5, which oxidizes 11-cis retinol to 11-cis retinal in the RPE, is also a 
disease gene linked to retinal dystrophy.  As the critical enzymes involved in major steps 
of the visual cycle were becoming better understood, it was still unclear which enzyme(s) 
was(were) responsible for the reduction of all-trans retinal, released following activation 
of rhodopsin and the cone opsins, to all-trans retinol that is returned to the RPE.  RDH12 
was found to be expressed in the photoreceptor cells by in situ hybridization, and 
displayed in vitro reductase activity toward retinaldehydes.  The RDH12-associated 
disease phenotype being distinct yet similar to that associated with other visual cycle 
genes, it was proposed that RDH12 might serve as the all-trans retinal reductase in the 
visual cycle. 
The work in Chapter 3 details the experiments undertaken to further 
understanding of the role of RDH12 within the context of the visual cycle.  A 
collaboration was begun with Dr. Christian Hübner of the Institut für Humangenetik 
(Hamburg, Germany) to develop an Rdh12–/– mouse, such that aspects of retinal 
histology, visual cycle function and visual response could be assayed in vivo.  My first 
priority was to examine the localization profile of RDH12 in the retina.  The subcellular 
localization of the RDH12 protein would help us to understand what role it might play in 
photoreceptor physiology, with a localization to the OS being a strong indicator of 
involvement in the visual cycle.  My approach to this end was the generation of an anti-
RDH12 monoclonal antibody, given no such antibody existed at the time. This antibody, 
mAb 2C9, displayed immunoreactivity towards human RDH12 but not mouse Rdh12.  
Our German collaborators generated two independent polyclonal antibodies against the 
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mouse ortholog, and one of these (rAb CSP) recognized the mouse epitope corresponding 
to the human epitope recognized by mAb 2C9.  Using these antibodies, I determined that 
RDH12 protein localizes to the photoreceptor IS and ONL in both human and mouse.  In 
addition, Rdh12 was not found to exhibit light-induced translocation between the IS and 
OS, as seen with other photoreceptor proteins such as transducin and arrestin [40-43]. 
The finding that the localization profile of RDH12 is similar in both humans and mice 
suggests that it plays a similar role in retinal physiology in both species.  However, the 
localization of RDH12 to the inner segments places it away from the site of 
phototransduction, complicating the view of RDH12 as the primary all-trans retinal 
dehydrogenase of the visual cycle.   
Our further analysis of the phenotype of the Rdh12–/– mouse revealed grossly 
normal histology, retinoid content, and visual response as measured by ERG.  We thus 
concluded that RDH12 does not limit visual cycle function, a finding which was in 
agreement with other studies of an independently generated Rdh12-deficient mouse 
[204]. It is not uncommon for mouse models to fail to show the human disease phenotype 
unless subjected to appropriate stress conditions or placed on a permissive genetic 
background [209]. While the Rdh12–/– mouse did not provide an immediate murine 
model of the human condition, it did allow us to study other aspects of RDH12 function 
in retinal physiology and pathology. 
In order to further characterize the role of Rdh12 deficiency in the murine model, 
I crossbred Rdh12 deficient mice onto backgrounds of increased light susceptibility 
(albino BALB/c, homozygous for the Rpe65-Leu450 (L/L) variant associated with high 
visual cycle throughput) and increased oxidative stress (Sod2+/–) and utilized these mice 
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in assays of various aspects of retinoid processing [132, 231]. In L/L mice, I observed 
that in vivo rates of all-trans retinal reduction and 11-cis retinal regeneration during 
recovery from bleaching were not affected by Rdh12 deficiency.  This led to a more in-
depth study into the reductive capacity of the mouse retinas in vitro, in which I observed 
a decrease in the overall ability of Rdh12–/– retinas to reduce both cis- and trans-
retinaldehyde substrates.  The decrease in reductive capacity towards visual cycle 
retinoids was found regardless of genetic background.  This is consistent with the 
viewpoint that RDH12 deficiency results in an alteration of retinoid metabolism within 
the retina, which may play a role in pathogenesis. 
In addition, wild-type mice with the Rpe65-M/M polymorphism exhibit lower 
levels of retinal reductase activity than mice with the Rpe65-L/L polymorphism 
associated with higher visual cycle activity. A collaborative effort between our lab and 
that of Dr. Janet Sparrow of Columbia University found that Rdh12-deficient mice 
exhibit elevated A2E levels in mouse eyecups that increase with aging.  This appears to 
correlate Rdh12 activity and visual cycle activity, with loss-of-function resulting in a 
shift in the equilibrium toward products that exit the visual cycle.  However, in vitro 
retinal reductase activity was not observed to change in Rdh12–/– mice crossbred on the 
Sod2+/– background, and we observed no changes in retinal histology for these animals 
or those on the light-susceptible albino background.  While this does not rule out the 
possibility that RDH12 functions in protecting against oxidative stress and light-damage, 
it does not appear to be its exclusive function. 
Subsequent in vitro studies by others showed that RDH12 also acts upon C9 
aldehydes resulting from lipid photo-oxidation, as well as certain steroid substrates [136, 
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139, 140, 216].  Additionally, a study of recombinant RDH12 activity found increased 
levels of retinoic acid in transfected cells expressing loss-of-function mutants relative to 
cells expressing the wild-type protein [229]. This suggested that RDH12 may contribute 
to additional pathways important for photoreceptor function. In an attempt to understand 
the potential role of RDH12 in the context of other retinal retinoid processing pathways, a 
collaboration with the laboratory of Dr. Joseph Napoli of the University of California, 
Berkeley was established to assess the levels of retinoic acid in the retina.  The 
aforementioned study suggested that reduction of retinaldehydes by RDH12 is required to 
protect against the potentially damaging effects of high levels of retinoic acid which can 
lead to apoptosis in many types of cells [237-239]. However, our studies showed that 
retinoic acid levels are decreased in the retinas of Rdh12-deficient mice.  While this does 
not support the view that RDH12 plays an exclusive role as a reductase in vivo to 
decrease levels of retinoic acid, it does suggest that the RDH12 deficiency alters certain 
aspects of retinoid metabolism in the retina. 
One critically important aspect of the work in Chapter 4 is that whereby we 
attempted to better understand the role of RDH in retinal physiology within the context of 
other RDH isoforms. Efforts to identify the RDH enzymes essential for visual cycle 
function have been confounded by the fact that photoreceptor cells express a number of 
isoforms which exhibit the necessary specificity in vitro [54, 55, 135].  Studies of mice 
deficient in Rdh5, Rdh11, and Rdh8 resulted only in mild phenotypes, suggesting 
redundancy in RDH function relative to the visual cycle mechanism.  We did not observe 
upregulation of any of the other RDH isoforms in the Rdh12–/– mice using microarray 
analysis.  While this does not identify a particular RDH isoform that compensates for 
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Rdh12-deficiency, it doesn’t rule out the possibility that normal levels of RDH 
expression in the mouse retina are sufficient for unperturbed visual cycle function and 
visual response. 
When taken in aggregate, our studies support the view that the primary role of 
RDH enzymes present in the photoreceptors may be to reduce potentially toxic levels of 
retinaldehydes in various cellular compartments. RDH8, which recognizes trans- but not 
cis-retinaldehydes, may serve to rapidly reduce all-trans retinal in the vicinity of the 
rhodopsin signaling complex in the OS.  RDH12, with its specificity for both all-trans 
and 11-cis retinaldhydes and localization near the metabolic source of NADPH, may be 
more important towards protecting the IS and the remainder of the inner retina under 
conditions of continuous illumination. Given the similar localization of RDH12 to the IS 
in both human and mouse retina and that no evidence of light-induced translocation 
exists, it can be inferred that all-trans retinal can move between OS and IS compartments, 
perhaps associated with retinoid-binding proteins or with opsin found in the inner 
segment plasma membrane (Figure 5-1).  
 
Future Directions 
The ultimate goals of research in the field of retinal dystrophy are to provide 
molecular diagnostics and novel treatments. Accomplishing these goals will require 
efforts combining the strengths of genetics, molecular biology, biological chemistry and 
vision science. Effective treatment regimes are only possible when a thorough knowledge 
of the normal function of the disease proteins and their context in retinal physiology has 
been ascertained. The encouraging results of Phase 1 gene therapy trials for the RPE65 
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gene provide a basis to expand this treatment to other retinal disorders. However, 
overexpression and mislocalization of therapeutic constructs can have detrimental effects 
in the course of therapy. Knowledge of disease mechanisms will be necessary to enable 
accurate analysis of the effects caused by variation in gene expression. Approaches such 
as microarray analysis and proteomics provide promising possibilities for determining the 
retinal pathways involved in retinal dystrophy. 
The failure of the Rdh12-deficient mouse model to replicate the phenotype of 
human disease may reflect differences between human and mouse relative to expression 
and/or catalytic activity of a second RDH isoform that maintains activity levels above a 
critical threshold in mouse, but not in human, retinas. If so, RDH11 is a likely candidate 
for providing this activity, as it is expressed in the photoreceptor inner segment, and no 
other RDH isoforms appear to be significantly up-regulated in Rdh12-deficient mice. In 
addition, the genes encoding RDH11 and RDH12 are highly related evolutionarily and 
are located in head-to-head orientation on the same chromosome in human and mouse.  
The generation of a mouse lacking both of these isoforms would be extremely 
advantageous in determining if Rdh11 compensates for lack of Rdh12 function in the 
mouse. Unfortunately, an Rdh12/Rdh11 double knockout mouse cannot be obtained by 
breeding due to the fact that the two genes are located within 8 kb of one another on 
mouse chromosome 12, too close for the two genes to spontaneously recombine.  Thus, 
an important future goal will be to produce a double knockout mouse using genetic 
engineering.  If Rdh11 can in fact compensate for Rdh12 deficiency in the mouse, one 
would expect to find a mouse phenotype more consistent with that found in human 
RDH12 loss-of-function patients.  This phenotype could range from small yet significant 
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decreases in all-trans retinal clearance as measured by HPLC to extreme cases of retinal 
cell death as measured by histology.  
 Another factor that could explain differences between the human and mouse 
phenotype is species differences in the intrinsic catalytic activities of RDH12.  While 
previous studies have evaluated the catalytic efficiency of recombinant human RDH12 
towards retinaldehyde and C-9 aldehyde substrates, no direct comparison to mouse 
Rdh12 activity has been published [136].  My latest work in lab has been the design and 
creation of baculoviral vectors encoding the human and mouse forms of RDH12 and 
RDH11 for expression in and purification from insect cells.  The decision to use an insect 
cell-based purification system was based on its suitability for expression of membrane 
associated proteins, the retention of posttranslational modifications that might be critical 
to RDH activity, and increased protein yield as compared to transfection of mammalian 
cells.  Preliminary work has yielded high titer baculoviral vectors, and early small scale 
purifications of RDH11 and RDH12 have been successful.  Once purified, it will be 
important to evaluate the kinetics of these proteins toward various retinaldehydes and 
other short-chain aldehydes, such as 4-hydroxynonenal [240].  A hypothetical result that 
might explain differences in the mouse and human phenotype would be a higher catalytic 
efficiency of human RDH12 than mouse Rdh12 for the reduction of all-trans retinal. 
The encouraging results of early RPE65 gene therapy trials make this one of the 
more promising methods of potential treatments for RDH12 patients.  In order to develop 
such gene replacement therapies, it will be necessary to gain a better understanding of the 
structure and function of the RDH12 promoter.  Just as promoter studies have been 
critical for targeting the RPE65 constructs currently being used in human gene therapy 
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trials, identification of the specific promoter elements of RDH12 will allow specific cell 
targeting and high level expression of potential gene therapeutics.  Misexpression of 
RDH12 to the wrong retinal cells could have drastic effects on both retinoid and visual 
processing.  For example, RDH12 misexpression in the RPE rather than the 
photoreceptor IS could potentially cause decreases in 11-cis retinal, the result of which 
might be akin to night blindness found in users of pharmaceuticals known to be RPE65 
antagonists (e.g. 13-cis retinoic acid) [241, 242]. Additionally, comparative analysis of 
the specific elements that regulate gene expression in human and mouse will aid in 
understanding the different outcomes resulting from RDH12 loss-of-function in each 
species. Early findings by our lab suggest that the genes encoding RDH11 and RDH12 
each have a single transcription start-site in human and mouse retina, and that promoter 
activity is present in the genomic region located directly upstream of the initiation codon.  
Identification of the key regulatory elements of the RDH12 promoter will help to ensure 
that gene replacement strategies lead to proper levels of expression in the appropriate 
cells. 
 
In conclusion, the studies presented in this dissertation provide significant insights 
into the role of RPE65 and RDH12 in the physiology of the RPE/retina and visual cycle 
mechanism.  Our localization of RPE65 to the RPE excludes a proposed direct role of 
RPE65 in a cone pathway of 11-cis retinal regeneration.   We also reached a better 
understanding of RPE65 structure and verified its interaction with RDH5.  We found that 
RDH12 protein expression was localized to the photoreceptor inner segments, and is not 
essential for visual cycle throughput. However, retinas of Rdh12–/– mice display a 
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decreased reductive capacity towards retinaldehydes.  In addition, transcript levels of 
Rdh12 correlate with visual cycle activity.  Thus our results suggest that RDH12 may act 
on all-trans retinal that gains access to the inner segments in constant illumination, 
possibly by means of carrier proteins, and that a critical function of RDH12 is the 
reduction of retinaldehydes that exceed the reductive capacity of the photoreceptor outer 
segment. The grossly normal phenotype of the Rdh12–/– mouse may be a result of 
compensatory mechanisms (possibly involving other members of the RDH family) that 




Figure 5-1. Schematic of RDH isoforms and retinoids present in the outer retina and 
RPE. Photoreceptor cells express a number of isoforms which exhibit the necessary 
specificity in vitro. Studies of retinoid processing in retina slices and isolated 
photoreceptor cells have shown that all-trans-retinol formation localizes to the outer 
segments during recovery from bleaching. The primary role of RDH isoforms present in 
the photoreceptors may be to reduce potentially toxic levels of retinaldehydes in various 
cellular compartments. It seems possible that RDH8 is important for the rapid reduction 
of all-trans-retinal in the vicinity of the rhodopsin signaling complex, whereas the 
contribution of RDH12, with its broader substrate specificity and localization near the 
metabolic source of NADPH, becomes more important under conditions of continuous 
illumination. As RDH12 is restricted to inner segments in both human and mouse retinas 
and we found no evidence of light-induced translocation, this implies that all-trans-retinal 
can move between outer and inner segment compartments, perhaps associated with 
retinoid-binding proteins or with opsin found in the inner segment plasma membrane. 
atROL, all-trans retinol; atRAL, all-trans retinal; atRE, all-trans retinyl esters; 11cROL, 
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